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Alzheimer‟s disease (AD) is a progressive neurodegenerative disorder caused 
by the degeneration of synapse and neuronal cell death in brain.  The hallmarks of AD 
are “amyloid plaques” and “neurofibrillary tangles”.  The amyloid plaques contain 
deposits of Aβ-peptide and the neurofibrillary tangles contain hyper phosphorylated 
tau proteins.  Recently it has been found that the soluble oligomers (dimers, trimers 
and tetramers) of the Aβ-peptide are the most neurotoxic.  The Aβ-peptide is 
generated by proteolytic processing of Amyloid Precursor Protein (APP).  In fact, APP 
undergoes proteolytic processing by two competing pathways: amyloidogenic 
pathway, which produces the toxic Aβ-peptide and non-amyloidogenic pathway, 
which is the major pathway in a healthy brain.  Identification of the signaling events 
that regulate APP processing pathways and Aβ-peptide levels in the cell is one of the 
key questions in AD research. 
Phosphorylation of T668 in APP intracellular domain (AICD) is an important 
signaling event that regulates APP processing.  T668 phosphorylation results in the 
partitioning of pT668-P669 peptide bond into cis and trans isomers.  The slow 
isomerization of these isomers is catalyzed by the only known human enzyme Pin1.  
Pin1 plays a neuroprotective role in AD.  This work attempts to elucidate how Pin1‟s 
enzymatic action influences the phosphorylation dependent signaling in AD.  
 
 
Combined NMR and ITC methodologies were used to determine kinetics and 
thermodynamics of pAICD:Pin1-WW domain interaction.  These studies led to the 
derivation of a mathematical framework that predicts the impact of isomerization rates 
on the effective binding affinities of isomer-specific interactions and on the time-
dependence of concentrations of isomer-specific complexes that could serve as entry 
points into modular protein interaction networks in the cell.  Pin1 activity is proposed 
to act as a switch that connects and modulates flux through cis/trans isomer-specific 
interaction networks which are otherwise insulated in its absence.  This work offers 
for the first time a direct molecular mechanism to explain the known influence of Pin1 
activity on diverse cellular functions under normal and disease conditions.  
Furthermore, peptide analogues were designed and synthesized for cis and trans 
isomers of pAICD.  These analogues are currently being used to identify the isomer-
specific binding partners in the cell. 
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CHAPTER 1 
INTRODUCTION TO ALZHEIMER’S DISEASE * 
 
Alzheimer‟s disease (AD) is a progressive neurodegenerative disorder caused 
by the degeneration of synapses and neuronal cell death in the brain (Mattson, 2004).  
It is characterized by progressive cognitive impairment that affects memory, 
orientation, logic and ability to perform everyday activities.  AD is the most common 
type of dementia, the other types being vascular dementia, fronto-temporal dementia 
and dementia with Lewy bodies.  Definite diagnosis of AD is done by the postmortem 
analysis of the patient‟s brain (Dickson, 1997) and should contain “amyloid plaques” 
and “neurofibrillary tangles” (NFT).  The amyloid plaques have been designated as the 
hallmark of this disease.  These plaques primarily contain deposits of a peptide called 
the Aβ-peptide and the neurofibrillary tangles contain hyper phosphorylated tau 
proteins.  The risk of AD increases dramatically in individuals above the age of 65.  
Since this illness affects the human mind and the quality of life, it has a devastating 
effect on both the patients and their dear ones.  In 2010 the total worldwide cost of 
dementia is estimated to be US$604 billion, 70% of which was incurred in Western 
Europe and North America (www.alz.org).  The organization Alzheimer‟s Disease 
International (ADI) estimates that currently 35.6 million people are living with 
dementia worldwide in 2010 and this number would increase to almost 115.4 million 
by 2050. 
Despite these staggering figures, efforts in drug development for Alzheimer‟s 
disease have intensified only recently, even though the disease was first described in 
1906 (Alzheimer, 1907).  Currently only five FDA-approved drugs for treatment of  
________________________________ 
* Parts of this chapter are based on a manuscript submitted to Nature Chemical Biology. 
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AD are available (www.nia.nih.gov/Alzheimer‟s).  These drugs temporarily slow the 
progression of the disease for an average of 6-12 months for approximately half of the 
individuals who take them.  These five drugs are donepezil, rivastigmine, tacrine, 
which belong to the class of cholinesterase inhibitors, galantamine which is an 
acetylcholinesterase inhibitor and memantine which is a NMDA (N-methyl-D-
aspartate) receptor uncompetitive antagonist.  Currently 56 drugs (Mangialasche et al., 
2010) are in various stages of clinical trials and 21 in preclinical trials.  These drugs 
target various aspects of AD such as amyloid formation, β-secretase inhibition, γ-
secretase inhibition and modulation, α-secretase activation, prevention of Aβ 
aggregation and oligomerization, promotion of Aβ clearance by immunotherapy, 
targeting tau protein, targeting mitochondrial dysfunction and targeted delivery of 
nerve growth factors.  Application of such diverse strategies for drug development in 
AD underlines the complex nature of this disease.  In 1970s, the “cholinergic 
hypothesis” (Bartus et al., 1982) emerged as the first attempt to explain the molecular 
basis of this disease.  Four out of the five FDA approved drugs are based on this 
hypothesis.  In mid-1980s the Aβ-peptide, which consists primarily of 40 or 42 amino 
acid residues, was identified from the meningeal blood vessels of patients with AD 
(Glenner and Wong, 1984b) and Downs syndrome (Glenner and Wong, 1984a).  
Later, this Aβ-peptide was identified as the major component of the senile plaque 
(Masters et al., 1985).  The gene of the β-amyloid precursor protein (APP), whose 
proteolytic cleavage produces the Aβ-peptide, was localized to chromosome 21, 
(Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987) 
which is linked to Downs syndrome.  Earlier it was observed that Downs syndrome 
invariably leads (Olson and Shaw, 1969) to the neuropathology of AD.  All these 
observations led to the proposal of the “amyloid hypothesis” which suggested that the 
aggregation of the Aβ-peptide leads to the neuropathology of AD. 
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The Cholinergic Hypothesis 
The cholinergic system (Carlton, 1963) is associated with the neurotransmitter 
acetyl choline (ACh) and its function in the central nervous system.  It is involved in 
storing and retrieving information in recent learning (Deutsch, 1971).  Age related 
studies in monkeys (Bartus et al., 1978; Bartus and Johnson, 1976) and humans 
(Bartus et al., 1982) have shown that dysfunction in this system is related to age 
dependent memory deficit.  The depletion of the cholinergic neurons in the ventral 
forebrain, resulting in disruption of cholinergic function in neocortex and 
hippocampus correlates well with dementia (Davies and Maloney, 1976; Wilcock et 
al., 1982).  The cholinergic hypothesis (Bartus et al., 1982) states that the deficiency in 
cholinergic neurotransmission is critical to the cognitive and behavioral symptoms in 
AD.  This led to the development of cholinesterase inhibitors (Wilkinson et al., 2004) 
as the first drugs for treatment in AD.  These inhibitors block the catabolic enzyme 
acetylcholine esterase (AChE), which degrades the neurotransmitter ACh, and thus, 
increase the lifetime of ACh in the synapse resulting in prolonged cholinergic 
neurotransmission.  Unfortunately, these drugs showed modest results (Frolich, 2002) 
as symptomatic treatment of AD.  The cholinesterase inhibitors are therapeutically 
valuable in modestly improving the conditions of patients with moderate dementia but 
fail in counteracting or significantly delaying their resurgence.  The inefficacy of the 
cholinesterase inhibitors, however, does not belie the cholinergic hypothesis.  The 
depletion of the cholinergic neurons leading to the impairment of the cholinergic 
system is an important event in the progression of AD and thus, is an important 
therapeutic target.  The significance of this hypothesis has been excellently summed 
up by Bartus (Bartus et al., 1986): “The cholinergic hypothesis necessarily suffers 
from a certain degree of inherent oversimplification and possible myopia. Yet, 
advantages gained by the research activities it helps stimulate and direct must not be 
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underestimated. It seems clear that the opportunity it provides for increasing our 
understanding of age-related memory problems and for developing an effective means 
of reducing the severity of the cognitive symptoms of aged brain and AD, provide 
adequate testimony for the continued value of the hypothesis as an important heuristic 
tool”. 
 
The Amyloid Hypothesis 
The amyloid hypothesis (Hardy and Selkoe, 2002) states that the accumulation 
of amyloid β-peptide (Aβ) results in the formation of amyloid plaques which causes 
neurodegeneration in the brain.  Later it was found that the soluble oligomers (dimers, 
trimers and tetramers) of the Aβ-peptide impair synaptic plasticity and behavior 
(Selkoe, 2008).  At picomolar concentrations these oligomers disrupt the basal 
synaptic transmission and long term potentiation in the hippocampus.  They were also 
found to interfere with the memory of the complex learned behavior in rats (Cleary et 
al., 2005).  Currently, the Aβ-peptide oligomers are considered to be the key to 
neurodegeneration in AD (Klein et al., 2001; Selkoe, 2002, 2008). 
The Aβ-peptide is generated by the proteolytic processing of the Amyloid 
Precursor Protein (APP), which is a transmembrane protein with a large extracellular 
domain, a transmembrane domain and a small intracellular domain (Figure 1.1a).  APP 
is expressed in various tissues including the neurons and glia of the brain.  Its pre-
mRNA is alternatively spliced resulting in three isoforms APP695, APP751 and APP770 
(Kitaguchi et al., 1988).  APP695, containing 695 amino acids, is the most abundant in 
neuronal cells (Tanaka et al., 1989).  APP is processed through two different pathways 
(Pastorino and Lu, 2006): the non-amyloidogenic and the amyloidogenic pathway 
(Figure 1.1a).  Non-amyloidogenic processing of APP involves cleavage by α-
secretase between Lys613 and Leu614 in the extracellular domain which produces the 
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ectodomain (sαAPP) and an 83 residue transmembrane fragment C83.  The potential 
candidates for the α-secretase are zinc metallanoproteinases such as ADAM9, 
ADAM10, TACE/ADAM17 and MDC9 (Allinson et al., 2003).  The fragment C83 
subsequently undergoes regulated intramembrane proteolysis (RIP) and is cleaved by 
γ-secretase.  The γ-secretase complex (Shah et al., 2005) consists of four proteins: 
presenilin (PS1 or PS2), nicastrin, APH-1 (APH-1aL, APH-1aS or APH-1b) and PEN-
2.  Presenilin is the catalytic component of the γ-secretase complex (Wolfe et al., 
1999).  Thus two more fragments are produced: p3, a 23 amino acid non-toxic peptide 
and a 59 amino acid APP intracellular domain (AICD).  The α-secretase cuts at the 
residue number 17 of the Aβ-peptide sequence resulting in p3 fragment which does 
not aggregate nor does it have any amyloidogenic activity.  Amyloidogenic processing 
involves the cleavage of APP by β-secretase in the extracellular domain followed by 
γ-secretase cleavage in the transmembrane region resulting in the production of a 
soluble ectodomain (sβAPP), 40/42 amino acid Aβ-peptide and AICD.  The major β-
secretase identified in neurons is BACE1 (β-site APP cleaving enzyme 1) (Sinha et al., 
1999; Vassar et al., 1999; Yan et al., 1999). 
 
Subcellular localization of APP processing 
APP is synthesized in the endoplasmic reticulum (ER) and then transported to 
the trans-Golgi-network (TGN) (Figure 1.1b), which is the steady-state residence site 
of APP in neurons (Greenfield et al., 1999; Hartmann et al., 1997).  From the TGN the 
APP is transported to the cell surface by secretory vesicles.  The APP can again get 
internalized into endosomes or lysosomes from the plasma membrane (Caporaso et al., 
1994; Nordstedt et al., 1993).  In neurons, APP is anterogradely transported along the 
axon which is mediated by its direct or indirect interaction to kinesin light chain 
subunit of kinesin-I (Kamal et al., 2000).  The subcellular distribution of APP has 
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Figure 1.1:  APP processing and its localization.  a)  The two proteolytic processing 
pathways of the transmembrane protein APP.  The green, red and yellow arrows 
indicate the α, β and γ secretase cut sites on APP.  The cleavage products generated in 
the two pathways are shown on the right.  b)  Location of APP and the three proteases 
in the cell.  The major sites of activity of the three proteases are also shown.  Figures 
a) and b) are adapted from Turner et. al. (Turner et al., 2003) with permission. 
7 
 
 
 
 
8 
 
direct impact on its processing fate (Zhang and Xu, 2007) and hence, in the 
pathogenesis of AD (Figure 1.1b).  The α-secretase cleavage of APP primarily occurs 
at the plasma membrane (Sisodia, 1992).  The β-secretase BACE1 requires an acidic 
environment for optimal activity and is primarily localized in late Golgi/TGN and 
endosomes (Vassar et al., 1999).  The γ-secretase complex resides mostly in the ER 
and TGN (Kovacs et al., 1996) and these are the major sites of APP processing by γ-
secretase (Greenfield et al., 1999; Xu et al., 1997).  The TGN, which is the major site 
of APP residence in neurons and also has acidic environment for β-secretase activity, 
is one of the major sites for the generation of secreted Aβ-peptide (Greenfield et al., 
1999; Xu et al., 1997).  The APP, which is not cleaved in the TGN, is transported to 
the plasma membrane where it can be cleaved by the α-secretase or endocytosed to the 
endosomal/lysosomal system.  The endosomal/lysosomal system is another major site 
for Aβ production (Haass et al., 1993a; Haass et al., 1993b).  In neurons APP is 
associated with axonal transport and the disruption of axonal transport has been shown 
to be an early pathogenic feature of AD (Lazarov et al., 2007; Stokin et al., 2005; 
Zhang et al., 2004).  The mechanism of this disruption and its effect on AD is not 
clearly understood (De Vos et al., 2008).  However, it is clear that the pathogenesis is 
mediated by increased Aβ production, since the disruption of the anterograde axonal 
transport of APP increases Aβ production (Stokin et al., 2005). 
 
The APP Intracellular Domain (AICD) 
The cytoplasmic tail of APP interacts with various cellular binding partners 
such as Fe65, Fe65L1, Fe65L2, Dab1, Mint1, Mint2, Mint3 and JNK-interacting 
protein family members (Ando et al., 2001; Borg et al., 1996; Duilio et al., 1998; 
Miller et al., 2006; Pietrzik et al., 2004; Sastre et al., 1998; Zambrano et al., 1998).  It 
contains the widely recognized NPXY endocytosis signal which contributes to its 
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internalization (De Strooper and Annaert, 2000).  Mutations within the YENPTY 
motif in APP inhibit its internalization and also decrease Aβ production (Perez et al., 
1999).  Binding to Fe65 facilitates the transport of AICD to the nucleus (Cao and 
Sudhof, 2001).  The cytoplasmic tail also contains eight potential phosphorylation 
sites (Y653, T654, S655, T668, S675, Y682, T686 and Y687) (Lee et al., 2003b; Oishi 
et al., 1997; Zambrano et al., 2001).  The residues T654 and S655 are phosphorylated 
by kinases such as protein kinase C (PKC) and calcium/calmodulin-dependent protein 
kinase II (CamKII).  These phosphorylation events supposedly favor the non-
amyloidogenic processing of APP (Buxbaum et al., 1993).  On the other hand, 
phosphorylation of Thr668 has been found to promote the amyloidogenic processing 
of APP (Lee et al., 2003b), β-amyloid production (Phiel et al., 2003), 
neurodegeneration (Lee et al., 2003a; Leroy et al., 2002) and also neuronal 
differentiation (Ando et al., 1999).  The T668 residue is followed by a proline residue 
and is phosphorylated by proline-directed kinases such as cyclin dependent kinases 
cdc2 and cdk5, the glycogen synthase kinase 3 (GSK3) and the c-Jun N-terminal 
kinase (JNK) (Lu et al., 2002a). 
The phosphorylation of T668 in APP is an important regulatory event in the 
pathogenesis of AD.  It was observed to be constitutively phosphorylated in the brain 
(Iijima et al., 2000).  APP phosphorylated on T668 (pAPP) was found to colocalize 
with BACE1 in enlarged endosomes, the site of Aβ production, of AD hippocampal 
neurons (Lee et al., 2003b).  The β-secretase cleavage product (C99) was found to be 
preferentially phosphorylated over the α-secretase cleavage product (C83) in AD brain 
and catecholaminergic cell lines (CAD cells).  Use of kinase inhibitors and T668A 
mutation significantly reduced Aβ generation in rat cortical neurons (Lee et al., 
2003b).  The AICD is generated after the γ-secretase activity in both non-
amyloidogenic and amyloidogenic processes but is mostly phosphorylated at T668 
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when processed through the amyloidogenic pathway (Lee et al., 2003b; Sodhi et al., 
2008).  The interaction complex of AICD and the adaptor protein Fe65 gets 
translocated to the nucleus and participates in gene transcription by forming a ternary 
complex with Tip60 (Cao and Sudhof, 2001).  Several target gene candidates of this 
regulation have been reported such as tetraspanin KAI1 (Baek et al., 2002), GSK-3β 
(Kim et al., 2003), nephrilysin (Pardossi-Piquard et al., 2005), APP, BACE and Tip60 
(von Rotz et al., 2004).  It does not regulate the transcription of ADAM10, PSEN1 and 
Fe65 (von Rotz et al., 2004).  It is not clear from these studies whether the AICD, in 
the ternary complex with Fe65 and Tip60, is phosphorylated at T668 or not.  Deletion 
of the endocytic signal YENPTY in AICD or T668A mutation abolished nuclear 
transport of AICD (Chang et al., 2006).  The use of inhibitors for the kinases cdc2, 
cdk5 and GSK-3β significantly reduced phosphorylation of T668 and nuclear 
translocation of AICD.  Thus, the phosphorylation of T668 seems to be important for 
the nuclear transport and transcriptional activity of AICD which in turn increases APP 
phosphorylation and processing through the amyloidogenic pathway (Chang et al., 
2006; Shin et al., 2007; Sodhi et al., 2008). 
 
Pin1 in Alzheimer’s disease 
When T668 in APP is not phosphorylated, its local, TPEE, forms a transient 
helix capping box structure (Figure 1.2a) while most of the APP cytoplasmic tail 
transiently samples nascent helix and other conformations (Ramelot et al., 2000).  The 
helix capping box structure stabilizes the trans conformation of the T668-P669 peptide 
bond.  Normally, the trans conformation in the Xxx-Pro peptide bond is destabilized, 
as compared to other peptide bonds, due to steric hindrance of the imide bond and 
hence, a minor population corresponding to the cis conformation is observed along 
with the trans conformation (Fanghanel, 2003).  Upon phosphorylation of T668, the  
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Figure 1.2  Cis and trans isomers.  a)  The TPEE region of the APP cytoplasmic tail 
forms a transient helix capping box structure which is predominantly trans with 
respect to the T668-P669 peptide bond.  Upon phosphorylation, the helix capping box 
structure is disrupted and both the trans and cis isomers can be detected by NMR.  
Pin1 catalyzes their isomerization.  b)  The dihedral angles of the trans and the cis 
isomers for the Xxx-Pro peptide bond are shown.  c)  Double bond character of the 
peptide bond provides significant transition energy barrier between the inter-
conversion of the two isomers.  Enzymes like Pin1 lower this barrier and catalyze the 
isomerization. 
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helix capping box structure is disrupted and the minor cis population becomes 
detectable (Ramelot and Nicholson, 2001) (Figure 1.2a).  The cis and the trans 
isomers in the Xxx-Pro peptide bond (Figure 1.2b) undergo slow isomerization 
(Fanghanel, 2003).  Rotation about this peptide bond is restricted (Figure 1.2c) due to 
its partial double bond character and hence, is slow (Fischer, 2000).  This 
isomerization is catalyzed by a class of enzymes known as peptidyl-prolyl isomerases 
(PPIases).  Pin1 (Lu et al., 1996; Ranganathan et al., 1997) is a mammalian PPIase 
that specifically catalyzes the cis-trans isomerization of the pSer/Thr-Pro bond. 
Pin1 has been shown to interact and catalyze the cis-trans isomerization of the 
pT668-P669 peptide bond in AICD (Pastorino et al., 2006) and is postulated to play a 
neuroprotective role in AD (Balastik et al., 2007).  In healthy brains Pin1 is mostly 
expressed in the soluble fraction (Thorpe et al., 2004) while in diseased brains it co-
localizes and co-purifies with NFTs leading to its depletion in soluble fraction (Lu et 
al., 1999a; Ramakrishnan et al., 2003).  Also Pin1 knockout mice develop age-
dependent neurodegeneration characterized by hyperphosphorylation of Tau protein 
leading to filament formation and Aβ-peptide formation and accumulation (Liou et al., 
2003; Pastorino et al., 2006).  Pin1 binds to the phosphorylated T231 (pT231) of the 
tau protein whose level of phosphorylation correlates with the progression of AD.  
Pin1‟s catalytic activity restores the ability of phosphorylated Tau to bind 
microtubules (Lu et al., 1999a) and also promotes Tau dephosphorylation by the 
phosphatase PP2A, which is trans-isomer specific (Zhou et al., 2000).  In transgenic 
mouse models, Tau hyperphosphorylation leading to Tau aggregation and Tau 
filament formation has been observed in aged Pin1 knockout mice (Liou et al., 2003).  
Moreover, the subcellular localization of Pin1 also points towards its neuroprotective 
role in AD.  Non-amyloidogenic processing of APP occurs at the plasma-membrane 
while the amyloidogenic processing occurs in the TGN and the endosomes/lysosomes.  
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Pin1 co-localizes with APP in the plasma-membrane and in clathrin coated vesicles 
but not in endosomes (Pastorino et al., 2006).  The overexpression of Pin1 in cell 
culture experiments showed reduced Aβ secretion while a significant increase in Aβ42 
was observed in the brains of Pin1 knockout mice (Pastorino et al., 2006).  Taken 
together, these data point towards a novel regulatory role of Pin1 in AD pathogenesis 
through its interaction with the phosphorylated cytoplasmic tail of APP and 
phosphorylated tau protein. 
 
Investigating the role of Pin1 in Alzheimer’s disease 
As presented above, there are compelling evidences that bring to light the role 
of Pin1 in AD, most probably a protective one.  Nonetheless, the underlying molecular 
mechanism is still unclear.  In fact, the direct interaction of Pin1 on APP still needs to 
be shown as influencing the APP processing pathways.  So far, the evidences are 
circumstantial.  Also the role of phosphorylation of T668 in APP cytoplasmic tail is 
not clear.  Its impact on APP processing is well demonstrated but the underlying 
molecular mechanism is still not known.  Phosphorylation of T668 in APP results in 
the emergence of a minor cis population with distinct structural features from the trans 
isomer.  We hypothesized that the cis isomer may favor the amyloidogenic processing 
of APP and the trans isomer may favor the non-amyloidogenic processing (Pastorino 
et al., 2006).  Pin1 activity ensures rapid re-equilibration between the two isomers 
whenever the equilibrium is disturbed due to dephosphorylation or phosphorylation, 
which are trans-isomer specific (Lu et al., 2002a), or due to isomer-specific binding 
events.  Absence of Pin1 would result in prolonged nonequilibrium between the two 
isomers which might favor the amyloidogenic processing of APP.  Thus, a key 
question would be the role of the cis isomer in the presence and absence of the trans 
isomer.  Do these isomers, in the full-length APP, play some role in endocytocis?  
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Also, what are the isomer-specific binding partners and what are their roles in the cell?  
In the AICD fragment, when translocated to the nucleus, do these isomers transcribe 
different sets of genes favoring one or the other processing pathway of APP?  These 
are all very intriguing questions which might go a long way in helping us understand 
the signaling pathways involved in AD and provide us with some therapeutic targets. 
The enzyme Pin1 is involved in diverse cellular functions under normal and 
diseased conditions.  It is involved in the regulation of cell-cycle progression, cellular 
stress response, immune response, neuronal differentiation and survival, and germ cell 
development (Lu and Zhou, 2007; Wulf et al., 2005).  Although the central role of 
Pin1 in multiple biological and pathological processes is now clear, precisely how its 
enzymatic action influences these processes is still not known.  The work presented 
here investigates the underlying molecular mechanism by which the enzymatic 
activity of Pin1 can influence such diverse processes.  In chapters 2 and 3, we present 
a detailed study on the kinetics and thermodynamics of the interaction of pAPP659-
682, a phophopeptide derived from the cytoplasmic tail of APP, and the isolated Pin1-
WW domain.  This study and subsequent derivation of a mathematical framework to 
predict the impact of cis-trans isomerization rates on effective binding affinities of 
isomer-specific interactions and on time-dependence of concentrations of isomer-
specific complexes enabled us to propose a powerful and novel role of Pin1. We 
propose that Pin1 acts as a switch in coupling protein interaction network modules, 
modulates flux through them and also modulates the effective binding affinities of the 
isomer-specific binding partners.  This provides for the first time a direct molecular 
mechanism to explain the known influence of Pin1 catalytic activity on diverse 
biological and pathological processes.  In chapter 4 we focus our attention to the 
design of molecular tools and probes to study cis and trans isomer-specific binding 
interactions.  We designed mimics for the cis and trans isomers of pAICD that are 
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being currently used in “fishing” experiments to identify the cis and trans-specific 
binding partners in the cell. 
In summary, this work provides a novel molecular mechanism to explain the 
impact of the catalytic activity of Pin1 on diverse biological and pathological 
processes.  We also provide NMR titration and lineshape analysis, ITC experiments 
and derived mathematical framework as a set of tools to investigate isomer-specific 
interactions and predict their impact on cellular functions.  Additionally, cis and trans 
mimics are developed as chemical tools to identify the putative isomer-specific 
binding partners in the cell and investigate their functions.  Thus, this work should 
pave the way for exciting and important research to understand the underlying 
signaling events in Alzheimer‟s disease and develop therapeutics for its cure. 
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CHAPTER 2 
KINETICS OF THE INTERACTION OF PIN1-WW DOMAIN AND 
PHOSPHORYLATED APP CYTOPLASMIC TAIL 
*
 
 
Introduction 
The peptidyl prolyl isomerase Pin1 is composed of two domains (Figure 2.1), a 
catalytic domain (PPIase) and a substrate binding domain (WW) (Ranganathan et al., 
1997).  Pin1 belongs to a class of enzymes called PPIases which catalyze the cis-trans 
isomerization of the Xxx-Pro peptide bond (Figure 1.2b).  PPIases are classified into 
three categories, namely, cyclophilins (Cyp) (Handschumacher et al., 1984), FK506 
binding proteins (FKBPs) (Harding et al., 1989) and parvulins (Rahfeld et al., 1994).  
Pin1 belongs to the class of parvulins which is unique from the other two classes due 
to the presence of an additional binding domain apart from the catalytic PPIase 
domain.  The binding domain, known as WW domain, is a peptide recognition module 
(PRM).  PRMs are protein domains that have been extensively used by nature as 
functional units that recognize and bind specific motifs (Pawson and Nash, 2003).  
Multicellular organisms possess nearly a thousand such modules (Chothia et al., 2003) 
and employ them for protein-ligand interactions which form the basis of complex 
signaling pathways.  PRMs are classified into families, each consisting of members 
that recognize specific motifs within the broad specificity of the family.  The WW 
domain is typically between 38 to 40 amino acids in length and derives its name from 
two conserved tryptophan residues.  The WW domain family is classified into five 
groups (I-V) based on specificity for different proline-rich recognition motifs 
(Verdecia et al., 2000).  Among them group IV, which is present in Pin1 and other  
_____________________________ 
* Parts of this chapter are based on a manuscript submitted to Nature Chemical Biology. 
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parvulins, is unique in that it is phosphorylation dependent, specifically recognizing 
phosphorylated Ser/Thr-Pro (pSer/Thr-Pro) motifs.  As with other modular functional 
units, WW domains are typically found as a contiguous part of larger, multidomain 
proteins (Sudol, 1996).  Such modular architecture of proteins where function (such as 
catalysis) and response to signal (such as binding activity) are physically separated, 
offer evolutionary advantages (Bhattacharyya et al., 2006; Jin et al., 2009) to the 
organism. 
Figure 2.1:  The ribbon structure of Pin1 (pdb code: 1F8A).  The catalytic PPIase 
domain (golden) and the substrate binding WW domain (cyan) are shown along with a 
phosphorylated peptide bound to the WW domain. 
 
The pSer/Thr-Pro motif is central to the proline-directed phosphorylation 
dependent signaling pathways (Lu et al., 2002a).  Pin1 specifically catalyzes the 
isomerization of this motif and regulates diverse cellular processes such as progression 
of the cell-cycle, cellular stress response, growth-signal response, immune response 
and neuronal function (Lu and Zhou, 2007).  Moreover, Pin1 has been implicated in 
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various diseases such as cancer (Lu et al., 2006) and Alzheimer‟s disease (Pastorino et 
al., 2006).  Pin1 is found to be over expressed in human cancers (Lu et al., 2006) and 
is receiving significant attention as a drug target (Xu and Etzkorn, 2009).  On the other 
hand, it plays a neuroprotective role and promotes the non-amyloidogenic processing 
of APP (Pastorino et al., 2006), thus preventing the production of neurotoxic Aβ-
peptide, thought to be a major causative agent of Alzheimer‟s disease (Li et al., 2010).  
Even though Pin1 has been found to be important for various cellular processes, it still 
remains to be elucidated how its enzymatic action influences these signaling 
pathways.  In order to understand the role of Pin1 and underlying molecular 
mechanism, it is important to elucidate the kinetics of its interaction with its 
substrates.  The phosphorylated AICD (pAICD) is an important biological substrate of 
Pin1 and the elucidation of their interaction will provide us with a better understanding 
of Pin1‟s role in AD. 
The interaction of Pin1 and its substrate involves six distinct states and can be 
represented by a reaction scheme (Figure 2.2a).  In this reaction scheme, each step 
corresponds to substrate binding, on-enzyme catalysis or substrate transfer between 
two domains.  Since the WW domain has no catalytic activity, the two WW domain 
bound states (C and F) are not connected (Lu et al., 1999b).  We aim to determine the 
microscopic rates of each step and identify residues in Pin1 that regulate those steps.  
This would elucidate the detailed workings of this enzyme.  Subsequent rational 
mutagenesis would allow us to understand and manipulate Pin1‟s influence on various 
signaling pathways.  In order to characterize this complex reaction scheme, we utilized 
the logical approach of divide and conquer.  Each of the two Pin1 domains are first 
studied independently and the resulting information is utilized as a restraint to model 
data obtained from the intact Pin1.  While the WW domain is a key element of the 
Pin1 reaction scheme, it is not yet known whether its role is simply to increase the 
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effective concentration of substrate (Lu et al., 1999b), to facilitate direct transfer of 
substrate to the catalytic domain (Jacobs et al., 2003), to facilitate subcellular 
localization (Lu et al., 2002b) or some combination of these possibilities.  However, it 
is clear that the WW domain is required for the in vivo functioning of Pin1, as shown 
by functional assay in yeast (Lu et al., 1999b).  The characterization of the Pin1 
reaction scheme (Figure 2.2a) should highlight the role of the WW domain in the 
functioning of the enzyme.  Here we present the binding kinetics of the Pin1-WW 
domain and a peptide derived from the cytoplasmic tail of APP, phosphorylated at 
T668 corresponding to states A-C and F and their connecting steps (Figure 2.2). 
 
 
 
Figure 2.2:  Pin1 reaction scheme.  a)  The reaction scheme for the interaction of Pin1 
with its substrate.  Each of the possible six states is denoted by a letter.  The 
connections of the steps correspond to uncatalyzed (A-B) or catalyzed (D-E) 
isomerization, binding to WW domain (A-F and B-C) or PPIase domain (A-E and B-
D) and substrate transfer (C-D and F-E).  The microscopic rates for each step are 
shown.  b)  The reaction scheme for the interaction of isolated Pin1-WW domain with 
its substrate.  The four microscopic rates of the two steps correspond to the same steps 
in the full-length Pin1 reaction scheme. 
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NMR Lineshape Analysis 
We utilized NMR lineshape analysis as our primary tool to study the binding 
kinetics.  The richness of information one might glean from the shape of an NMR 
peak has been known since the early days of NMR spectroscopy (Rao, 1989).  
However, this information has been largely untapped, having taken a backseat to the 
more high-profile applications of NMR to proteins, such as structure determination 
(Wuthrich, 1990) and relaxation-based NMR methods (Kay, 2005; Palmer, 2004; 
Palmer et al., 2005) for extracting motions on various timescales.  NMR lineshape 
analysis has been sparsely used in the study of proteins, some examples being the 
determination of protein-ligand interaction kinetics (Gunther and Schaffhausen, 2002; 
Kovrigin and Loria, 2006) and enzyme catalysis (Kern et al., 1995).  In comparison, 
the relaxation-based NMR methods such as CPMG (Korzhnev and Kay, 2008) and 
R1ρ (Massi et al., 2004) experiments have been widely applied to study μs-ms 
motions in proteins (Loria et al., 2008). While CPMG and R1ρ experiments can be 
used to characterize exchange between two or three states, lineshape analysis can 
handle complex reaction schemes involving multiple states.  Additionally, lineshape 
analysis is well suited to study systems where titration experiments are of interest, 
such as protein-ligand interactions.  Hence, the lineshape analysis method expands the 
scope of NMR studies of protein kinetics and thermodynamics, since it can be used to 
study any reaction scheme where the NMR lineshape can be systematically varied as a 
function of some known parameter such as ligand concentration, pH or temperature.  
Only one spectrum, such as 
15
N-
1
H HSQC, needs to be collected for each titration 
point and the collective dataset is simultaneously analyzed.  The 
1
H and 
15
N lineshapes 
for each residue obtained from a 
15
N-
1
H HSQC experiment provide independent 
detectors of μs-ms motions for each residue giving additional restraints for the 
reaction scheme.  It is important to note that since the number of fitted parameters 
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increases rapidly with the complexity of the reaction scheme and hence, for complex 
systems it is necessary to use additional independent experiments to restrain the 
parameter space. 
The reaction scheme for the isolated WW domain is a simple model and served 
as an excellent test case for the lineshape analysis.  We performed the analysis from 
both the protein and the peptide perspectives, which report on the same binding event, 
and compared the fitted parameters obtained.  Excellent agreement in the fitted 
parameters from the two perspectives provided confidence in the applicability of this 
approach for characterization of more complex reaction schemes of the PPIase domain 
and, ultimately, intact Pin1.  As long as enough experimental perspectives are 
accessible, accurate kinetic and thermodynamic parameters for a given multistate 
reaction can be determined. 
 
Materials and Methods 
Protein expression and purification 
The WW domain vector was generously provided by Dr. Kun Ping Lu, 
Harvard Medical School.  The gene sequence is encoded in pET28 a(+) expression 
vector, which has His6 as the affinity tag, thrombin cleavage site and Kanamycin 
resistance.  This construct (WWold) has residues 1-53 of full length Pin1 and has Gly-
Ser-His as the three extra N-terminus residues after thrombin cleavage.  A new 
construct was made by removing the extra N-terminus histidine residue and this 
construct was named as WW_Hdel.  Furthermore, the three terminal residues Glu-Pro-
Ala were also removed so that the construct has 50 WW domain residues and it was 
named WW50. 
The vectors were transformed into BL21 DE3 Escherechia coli cells for 
protein synthesis.  For the 
15
N-labeled protein, the bacteria were grown in M9 minimal 
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media at 37°C with 
15
NH4Cl as the sole nitrogen source.  For unlabeled protein, the 
bacteria were grown in 1L Lysogeny Broth (LB).  The protein expression was induced 
with 1mM isopropyl β-D-1-thiogalactopyranoside when OD at 600 nm reached 0.8, 
and cells were harvested after 4 hours.  The cells were lysed in 20ml lysis buffer 
(25mM HEPES, 150mM NaCl, 10mM Imidazole 100µl protease inhibitor cocktail, 
5mg lysozyme and pH = 7.5) and sonicated on ice.  The cell debris was removed by 
centrifugation and the supernatant passed through 2ml Ni-column pre-equilibrated 
with wash buffer (25mM HEPES, 150mM NaCl, 10mM Imidazole and pH = 7.5).  
The column was washed with 10 bed volumes of wash buffer and 5 bed volumes of 
cleavage buffer (20mM Tris-HCl, 150mM NaCl, 2.5mM CaCl2 and pH=8.4) leaving 1 
bed volume of the cleavage buffer in the column.  Biotinylated thrombin (Novagen 
Thrombin Cleavage Capture Kit) was used to cleave the WW domain on the column.  
The protein concentration was measured by UV absorption at 280 nm and also by 
Bradford assay.  The thrombin was removed by adding streptavidin-agarose beads 
which were removed by spin columns.  Purity of the protein was verified by SDS 
polyacrilamide gel electrophoresis (PAGE).  The purified 
15
N labeled protein was 
dialyzed into final buffer (10mM Citric acid, 10mM NaCl, 1mM DTT, 5mM NaN3, 
pH = 6.9) overnight at 4°C.  The unlabeled protein was dialyzed into a final buffer 
containing 10mM HEPES, 10mM NaCl, 1mM DTT, 5mM NaN3 and pH = 6.9.  For 
the NMR experiments 5µl of PI cocktail was added to 300µl of protein sample. 
Peptide Synthesis 
The unlabeled peptide consists of the residues 659 to 682 and the labeled 
peptide consists of residues 659 to 679, respectively, from the cytoplasmic tail of APP.  
The unlabeled peptide is denoted as TAR2 and the labeled peptide as 15NTAR1.  In 
earlier titration experiments, the unlabeled peptide used consisted of residues 659 to 
679 and was denoted as TAR1.  The purified 15NTAR1 and TAR2 phosphopeptides 
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were purchased from the Tufts University Core Facility, Boston.  Along with the 
peptide, analytical reverse phase HPLC analysis (>99%) and MALDI-TOF mass 
spectrometry analysis was also obtained.  The relevant peptide was weighed out, as 
required, dissolved in 200μl de-ionized H2O, adjusted to pH ~7 using NaOH and 
lyophilized.  The lyophilized peptide was dissolved in the final NMR buffer.  The pH 
of the sample adjusts to the pH of the buffer.  The concentration is measured using 
tyrosine extinction coefficient of 1400 M
-1
cm
-1
 (Creighton, 1993).  Rough 
concentration measurements for the 15NTAR1 and TAR1 peptides were done based 
on mass as it lacks any tyrosine or tryptophan residues.  A correction for the 
concentration of the peptide was used as a fitted parameter in the lineshape analysis. 
NMR titration experiments 
Two titration experiments were performed: 
15
N peptide (15NTAR1) titrated 
with unlabeled WW-domain (WWold) and 
15
N WW-domain (WW50) titrated with 
unlabeled peptide (TAR2).  For the 
15
N- peptide titration, the most saturated sample 
was prepared first containing 0.65 mM peptide and 1 mM WW domain.  In the 
subsequent titration steps, part of the previous sample was diluted with 0.65 mM 
peptide to get the required molar ratio and a final volume of 300 μl.  Eight titration 
points were collected; the 
15
N peptide (15NTAR1) concentration kept constant at 0.65 
mM while the WW (WWold) concentration was 0, 0.01, 0.05, 0.1, 0.2, 0.33, 0.5 or 1 
mM.  Similarly for the 
15
N WW titration, the most saturated sample, 0.4 mM 
15
N WW 
domain (WW50) and 6.6 mM peptide (TAR2), was prepared first.  The subsequent 
steps were obtained by diluting with 0.4mM 
15
N WW domain.  Eleven titration points 
were collected with peptide concentrations of 0, 0.044, 0.088, 0.176, 0.264, 0.352, 
0.44, 0.88, 2.2, 4.4 and 6.6 mM.  For each titration point a 
15
N-
1
H HSQC spectrum 
was collected.  All experiments were carried out at 25°C on a Varian Inova 600-MHz 
spectrometer.  For the labeled protein titrations 2048×256 complex data points and for 
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the labeled peptide titrations 2048×128 complex data points were acquired.  The 
spectra were processed using NMRpipe (Delaglio et al., 1995) and visualized with 
Sparky (Goddard, 2008).  The exponential decay window function was applied to all 
data in order to preserve the lorentzian lineshape and then zerofilled. 
The construct WWold was initially used for the titration experiments.  
Concentrated TAR1 was added to 
15
N-WW for each titration point.  The protein 
concentration was 1mM and the ratio of the peptide to protein used was 0, 0.156, 
0.320, 0.493, 0.675, 0.867, 1.071, 1.824, 2.531 and 6.828. 
Lineshape analysis 
The lineshape analysis was performed according to the method described by 
Beach (Beach et al., 2005) and Gunther (Gunther and Schaffhausen, 2002) using the 
package BiophysicsLab (Kovrigin, E.L., manuscript in preparation, 
http://biophysicslab.net).  BiophysicsLab treats 1D slices of each dimension (
1
H, 
15
N) 
of each peak from a titration series as an independent dataset.  The area under each 
peak is normalized in order to eliminate the effect of line broadening in the orthogonal 
dimension.  For the lineshape fitting, the equilibrium populations of the free trans 
isomer, free WW domain and bound WW domain were determined from the reaction 
scheme (Figure 2.2b).  The populations (pi where i is A, B, etc.) of the free and bound 
species are expressed in a column vector.  The relaxation rate constant for each species 
(R2) are calculated from the linewidths of the free and the bound peaks and expressed 
as diagonal elements of a square matrix (left term, equation 2.1a).  Similarly, the 
chemical shifts (νi) of the free and the bound species are expressed in a matrix (right 
term, equation 2.1a).  The rate constants (ki) are expressed in the rate-matrix which is 
derived from the equilibrium rate equations of each species (middle term, equation 
2.1a).  Finally, the spectrum at the frequency ν is calculated using equation (2.1c).  
The independent variable chemical shift parameter (ν) which constitutes the 
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independent variable dimension in the simulated spectrum is represented by equation 
(2.1b). 
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The quality of the fitting was determined from the sum of squares of the 
residuals (SS) which is determined as               
 
  
  
  
 
 
 , where fij and yij 
are the calculated and actual NMR signal at a frequency νi respectively, σj is the noise 
rmsd of spectrum „j‟, Nj is the number of data points in spectrum „j‟ and M is the 
number of titration points.  For the practical aspects of lineshape analysis using 
BiophysicsLab, see Appendix 1. 
 
Results 
Isomer-specific interaction of pAPPc with the Pin1 WW domain 
In order to study the Pin1-WW domain (hereafter referred to as WW domain) 
in action we chose one of its natural substrates, a peptide (pAPP659-682) derived from 
the amyloid precursor protein (APP) phosphorylated at T668.  We looked at the 
interaction from both the protein and the peptide perspective by titrating in the 
unlabeled peptide into 
15
N-labeled WW domain and the unlabeled WW domain into 
the 
15
N-labeled peptide respectively.  For each titration point 
15
N-
1
H HSQC spectra 
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were collected.  The pT668-P669 peptide bond of the substrate exists in two isomeric 
forms, cis and trans.  The labeled peptide contains 
15
N-labels for the amide nitrogen of 
the residues E667 and V670, which are sensitive to the isomeric state of the pT668-
P669 peptide bond.  The 
15
N-
1
H-HSQC spectra of this peptide shows distinct cis and 
trans peaks for both the residues (Figure 2.3).  Upon titration with unlabeled WW 
domain the peaks corresponding to the trans isomer exhibit fast exchange relative to 
the NMR timescale, resulting in peak shifts from the free to the bound positions 
(Figure 2.3).  The corresponding peaks of the cis isomer do not move appreciably and 
gradually diminish via conversion to the trans isomer as the concentrations of free cis, 
free trans and the bound trans equilibrate with increasing concentration of the WW 
domain.  In the final titration spectrum only the bound trans peaks are observed.  
Thus, the interaction of this peptide to the WW domain can be represented by two 
steps, isomerization of the cis and trans isomers, and binding of the trans isomer to 
the WW domain (Figure 2.2b). 
Previously, it was reported that addition of WW domain to this peptide caused 
significant peak shifts for both the cis and trans isomers, indicating similar affinity for 
these distinctly different structures (Pastorino et al., 2006).  In this earlier work, the 
concentrations were lower (0.2 mM peptide, 0 and 0.2 mM WW), which would reduce 
the relative population of bound trans (c.a 0.7) and cause the trans peak corresponding 
to E670 to be broadened.  Furthermore, the position of E670 cis peak is highly 
sensitive to pH in the mildly acidic to neutral pH range due to its interaction with the 
titrating phosphate group, while the V668 cis peak remains unperturbed (Figure 2.4).  
Accounting for pH and concentration effects, the previously reported and current 
results demonstrate that the cis interaction with the WW domain is weak, and the 
behavior of the peak corresponding to the E670 cis isomer is highly sensitive to 
sample conditions. 
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From the protein perspective the effect of the peptide binding is felt throughout 
the core of the protein.  Out of 26 residues (G10 to E35) that constitute the core 
structure of the WW domain (Figure 2.5a), 22 backbone amides show appreciable 
chemical shift change in response to the peptide binding (Figure 2.5b).  These 
chemical shift perturbations provide us with several reporters throughout the protein 
that report on the same binding event.  In order to obtain the kinetics of this 
interaction, lineshape analysis was performed on both sets of titration data. 
 
Figure 2.3:  Overlay of 
15
N-
1
H HSQC spectra of the titration of the 
15
N-labeled peptide 
with isolated WW domain.  Very little peak shift is observed for the cis peaks whereas 
the trans peaks move considerably.  The cis peaks are not visible in the final spectrum 
(dark blue) indicating complete conversion to bound trans. 
 
Determination of kinetic parameters for interaction of trans isomer and WW 
domain 
In addition to confirming the residues in the WW domain that are interacting 
with the pAPP659-682 peptide, the chemical shift changes along with the change in  
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Figure 2.4:  Overlay of 
15
N-
1
H HSQC spectra for pH titration of 
15
N-labeled peptide 
(15NTAR1).  E670 is highly sensitive to pH titration. 
 
Figure 2.5:  a)  Primary sequence and secondary structure of the WW domain denoting 
the core of the protein.  b)  Composite chemical shift change (Ayed et al., 2001; 
Mulder et al., 1999) for each residue between the free and bound states, where 
       
       
      
 
             
       
      
 
.  The chemical shifts δfree 
and δbound are obtained from the free and the most saturated spectra of isolated 15N 
WW domain respectively. 
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NMR lineshapes also provide information on the kinetics and binding affinity of this 
interaction.  The chemical shift difference () between two exchanging states (e.g. 
free and bound) determines whether a chemical exchange process is in fast (kex > ) 
intermediate (kex ~ ) or slow (kex < ) timescale, where kex is the rate constant of 
exchange.  In the fast timescale a single sharp peak is observed at the population 
weighted average chemical shift.  Intermediate timescale results in a single broad peak 
corresponding to the trans isomer in the labeled peptide move from the chemical shift 
of the free state to that of the bound state (Figure 2.3), indicating that the interaction 
occurs on the fast timescale.  During the titration the peaks progressively broaden with 
the addition of peptide and then narrow as saturation is reached.  Similar behavior is 
observed for the lineshapes in the labeled WW domain upon interaction with the 
peptide.  Information regarding the kinetics of the binding event is contained in these 
broad and narrow lineshapes and can be extracted by lineshape analysis(Kern et al., 
1995). 
Lineshape analysis on titration data from both perspectives was performed 
whereas in the slow timescale distinct peaks are observed at the respective chemical 
shifts of the exchanging species. Upon interaction with the WW domain, the peaks 
using the reaction scheme (Figure 2.2b) for the WW domain and pAICD interaction.  
The populations of the free cis isomer, the free trans isomer, the free WW domain and 
the bound WW domain were calculated according to this scheme.  Since the intrinsic 
cis to trans inter-conversion rate is very slow (timescale on the order of minutes, vide 
infra), this rate does not affect the NMR lineshapes and only affects the populations of 
the two isomers.  The titration experiments were performed under equilibrium 
conditions and hence, the free isomers maintain their equilibrium populations.  The 
NMR lineshapes were fit to a two state model (free and bound states) while 
accounting for the thermodynamic coupling to the cis-trans equilibrium.  The  
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Figure 2.6:  a)  Individual fitting of the 
15
N-peptide titration lineshapes.  b)  
Simultaneous fitting of the three datasets.  The quality of the fit are the same for 
individual and simultaneous fittings.  The filled circles (•) represent the NMR data and 
the solid line is the simulated spectrum. 
 
populations were determined from the volumes of the peaks corresponding to the trans 
and the cis isomers in the 
15
N-
1
H HSQC spectra of the peptide (Figure 2.3).  The 
simulated lineshapes based on the two-state model fits the 
15
N-labeled peptide titration 
data well (Figure 2.6a).  The fitting parameters are the binding constant (KD), the off 
rate (kCB) and the chemical shift of the bound species (δbound), since saturation is not 
reached in these titration experiments.  We designate the first two parameters (KD and 
kCB) as global parameters since they should be the same for all residues, and the 
chemical shift of the bound state, δbound, as a local parameter since it is unique to each  
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Figure 2.7  Overlay of 
15
N-
1
H HSQC spectra for the titration of 
15
N-WW domain with 
unlabeled peptide.  Peaks for three representative residues are shown on the right 
column.  These peaks were used in simultaneous fitting. 
 
Figure 2.8:  Representative examples of the individual fitting of the lineshapes from 
isolated 
15
N-WW domain titration data. 
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Table 2.1  Fitted parameters from individual fitting of three datasets of the labeled 
peptide titrated with unlabeled WW domain 
 
 
kCB (s
-1
) kBC (M
-1
s
-1
) KD (μM) 
E22H 2511.80 4.9×10
7
 50.7 
E22N 1962.21 5.0×10
7
 38.9 
V19H 2461.65 4.8×10
7
 50.3 
 
 
Table 2.2:  Comparison of the sum-of-squares (SS) for individual (I) and simultaneous 
(S) fitting. 
 
Residue I (×10
5
) S (×10
5
) S/I Residue I (×10
5
) S (×10
5
) S/I 
E12H 3.95 4.81 1.219 N26H 4.46 4.66 1.045 
K13N 11.8 20.9 1.776 H27N 33.1 61.5 1.857 
R14N 43.4 78.9 1.819 H27H 4.59 7.47 1.627 
M15H 5.92 9.19 1.551 N30N 33.8 38.5 1.138 
S16H 1.46 2.45 1.676 N30H 13.0 22.4 1.719 
G20H 3.17 6.92 2.183 A31H 8.77 15.2 1.731 
V22N 38.2 69.3 1.815 S32H 9.86 9.97 1.012 
Y23N 23.8 56.1 2.361 Q33H 2.50 3.50 1.400 
Y24N 10.7 16.2 1.519 W34N 14.0 18.1 1.290 
Y24H 2.41 3.28 1.358 W34H 1.19 3.70 3.100 
F25H 3.83 5.57 1.454 W34eH 19.1 61.3 3.206 
    
E35H 9.85 12.8 1.302 
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residue.  The two dimensions, 
15
N and 
1
H, for each peak are treated as separate 
datasets.  The 
15
N dimension of the V667 trans peak was not considered due to small 
chemical shift change upon binding.  The three datasets for the two trans peaks were 
fit both individually (Table 2.1) and simultaneously (Figure 2.6b).  The simultaneous 
fitting yields KD = 42.5 ± 1.9 μM, kCB = 2260 ± 60 s
-1
 and kBC = 5.3 ± 0.2  10
7
 M
-1
s
-1
 
from the ligand‟s perspective, where best fit and the 95% confidence interval is 
reported for each parameter.  The confidence intervals are computed from Monte-
Carlo simulations. 
To obtain the kinetics of the same binding event from the WW domain‟s 
perspective, lineshape analysis was performed on the 
15
N WW domain titration data.  
Out of the 22 residues which display appreciable chemical shift change upon peptide 
binding, 17 residues gave rise to peaks that were resolved through the entire course of 
the titration (Figure 2.7).  Individual fitting of these 17 residues yielded reasonable 
agreement in global parameters (Figure 2.8 and Table 2.2).  Simultaneous fitting 
(Figure 2.9) was performed on datasets corresponding to seven residues (K13N, 
R14N, G20H, N26H, H27H, Q33H and W34H) that undergo the most chemical shift 
change and hence, contain the maximum information of the binding event.  In 
excellent agreement with the global parameters obtained from the ligand perspective, 
the WW domain perspective simultaneous fitting yielded KD = 34 ± 0.3 μM (best fit ± 
95% confidence interval) and kCB = 2170 ± 40 s
-1
, and kBC = 6.4 ± 0.1 ×10
7
 M
-1
s
-1
, 
where the confidence intervals are computed from monte carlo simulation.  In order to 
check whether these fitted parameters are truly global for all the 17 residues, these 
parameters were used to simulate their lineshapes.  The quality of fit, measured by the 
sum of squares of the residuals (SS), were very similar to those obtained from the 
individual fitting of the 17 residues.  Thus, the parameters obtained from the 
simultaneous fitting truly represent the global behavior of the binding interaction.  As 
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a further step to global modeling of the binding mechanism, seven datasets from the 
15
N WW domain and the three datasets from the 
15
N peptide were simultaneously fit 
(Figure 2.10) which resulted in KD = 35.1 ± 0.4 μM, kCB = 2220 ± 30 s
-1
 and kBC = 
6.3± 0.1 × 10
7
 M
-1
s
-1
, where the confidence intervals are computed from Monte-Carlo 
simulations. 
 
Figure 2.9:  Simultaneous fitting of seven 
15
N-WW domain datasets.  Black peak 
represents free protein. 
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Interestingly, the initial titration experiments performed with 
15
N-labeled 
WWold construct and unlabeled peptide, TAR1, displayed broader lineshapes for the 
free protein as compared to the saturated spectrum (Figure 2.11a).  The WWold 
construct has 1-53 Pin1 residues, the last three being E51, P52 and A53.  The last few 
residues in this construct are in a flexible tail (Figure 2.5b) and the E51-P52 peptide 
bond mimics the pS-P peptide bond.  The peaks corresponding to the cis and the trans 
isomers are distinctly visible in the 
15
N-
1
H HSQC spectrum of this WW domain 
construct (Figure 2.11b).  Hence, it was reasoned that the trans isomer of E51-P52 in 
the tail weakly interacts with the binding site of the WW domain.  This results in the 
broadening of the core residues of the 
15
N-WW domain due to fast exchange between 
the free and the bound states.  When the phosphorylated peptide (TAR1) is titrated 
into this protein, it competes off the weak E51-P52 binding and under saturating 
condition there is only one bound state, i.e. 
15
N-WW to TAR1, which has narrower 
lineshape than the free protein (Figure 2.11a).  In order to confirm this hypothesis the 
last three residues were removed from the WW domain resulting in the construct 
WW50.  The relative broadening of the free WW domain peaks as compared to the 
phosphopeptide bound peaks was eliminated in this construct (Figure 2.11c).  This 
observation highlights the sensitivity of the NMR lineshapes even to weak interactions 
which can arise from intramolecular interactions, buffer components, etc.  The above 
observations can be summarized in a model (Figure 2.11d).  When the WWold is 
saturated with phosphopeptide the flexible tail is mostly free and the E51-P52 peptide 
bond only undergoes exchange between the two isomers.  Hence, from the ratio of the 
peak heights, the equilibrium constant Kisom,EPA was determined to be 7.9, which  
agrees well with reported value of Glu-Pro peptide bond (Reimer et al., 1998).  In the 
free protein E51-P52 undergo exchange between the three states G, H and I.  The state 
G gives rise to the cis peak in 
15
N-
1
H HSQC spectrum (Figure 2.11b).  The states H  
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Figure 2.10:  Simultaneous fitting of seven residues from the 
15
N-WW domain and 
three residues from the 
15
N-peptide. 
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and I are in fast exchange and give rise to the trans peak in the same spectrum.  
Hence, the following relation can be deduced between the ratio (R) of the trans and cis 
peaks, the equilibrium constants Kisom,EPA and Kbind,EPA: 
  
       
   
 
   
   
 
   
   
 
   
   
 
   
   
 
   
   
  
 
   
   
    
   
   
                            (2.2) 
The ratio (R) was determined to be 8.95.  Using equation (2.2), Kbind,EPA was 
determined to be 0.136. 
 
Discussion 
Here we have used NMR lineshape analysis to characterize the kinetics of the 
interaction of the Pin1-WW domain with the cytoplasmic tail of APP, phosphorylated 
at T668.  This binding interaction was investigated from both the protein and the 
peptide perspective by using 
15
N-labeled protein and 
15
N-labeled peptide, respectively.  
Use of the 
15
N-labeled peptide revealed that the binding of the WW domain to the cis 
isomer is very weak and can be neglected.  This suggests that the Pin1 reaction 
scheme can be simplified to a five-state system (Figure 2.12).  The off-rates (kCB) 
obtained from the two perspectives are in good agreement, validating our approach.  
To our knowledge, this is the first detailed kinetic study of the interaction of a WW 
domain with its substrate. 
One of the most intriguing questions regarding the WW domain in Pin1 is its 
role in the functioning of the enzyme.  It is well understood that enzymes utilize the 
enzyme-substrate binding energy for catalysis (Fersht, 1974).  WW domain increases 
the binding affinity of Pin1 by several orders of magnitude and hence, some of its  
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Figure 2.11:  Titration of WWold.  a)  Cross sections of the 
1
H-dimension of S16 in 
free (black) WWold and saturated (red) with phosphopeptide.  The peaks are 
normalized i.e. have unit area.  Hence, the shorter peak has greater full-width at half-
height.  b)  
15
N-
1
H HSQC spectrum of the free WWold.  The cis and the trans peaks of 
E51 are assigned.  c)  Cross sections of the 
1
H-dimension of S16 in free (black) 
WW50 and saturated (red) with phosphopeptide.  The black peak is slightly higher 
than the red peak.  d)  Model for WWold.  The curvilinear line represents the C-
terminal linker after the WW domain and the last last three residues are shown by 
single letter codes.  The E51-P52 peptide bond in the flexible tail can exist as cis or 
trans isomer.  The trans isomer binds the protein which is competed off by the 
phosphopeptide binding.  Each state is denoted by a letter. 
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Figure 2.12:  Revised reaction scheme of Pin1 and its substrate.  The weak interaction 
of the cis peptide to WW domain has been eliminated from the reaction scheme and 
the rate constants determined for the binding of the trans peptide to the WW domain is 
shown. 
 
binding energy should contribute to the overall catalytic efficiency of the enzyme.  
Another way to view this is by considering the internal equilibrium constant of an 
enzyme which should be close to 1 for a perfect enzyme (Albery and Knowles, 1976).  
The internal equilibrium constant is the equilibrium constant of the enzyme-bound 
species, i.e. the bound cis and bound trans in the case of Pin1.  Since the WW domain 
differentially binds to these two isomers, its presence would change the internal 
equilibrium constant of Pin1 and it can be speculated that this change can bring it 
close to 1 as the presence of WW domain in Pin1 is evolutionarily favored.  This 
would argue for the presence of a substrate transfer step (Figure 2.12) between the 
WW domain and the PPIase domain.  Also it is interesting to note that the substrate 
off-rate (2200 s
-1
) for the WW domain is in roughly the same time regime as the on-
enzyme catalysis rate (1200 s
-1
) of the isolated Pin1-PPIase domain (Labeikovsky et 
al., 2007) and these two steps are connected by the substrate transfer step (Figure 
2.12).  The kinetic synchronization of these two steps might be important in the 
overall catalytic activity of the enzyme and should be evident from the complete 
analysis of the reaction scheme of full length Pin1. 
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The NMR titration experiments and lineshape analysis of the titration data 
provide an excellent experimental tool to study kinetics of isomer-specific 
interactions.  Also the excellent agreement between the ligand and the protein 
perspectives reporting on the same binding event provides us with confidence 
regarding the applicability of this method to the more complex reaction schemes of the 
PPIase domain and the full length Pin1.  Additionally, our detection of a weak 
intramolecular interaction binding between the linker region (E51-P52) and the WW 
domain binding surface highlights the sensitivity of NMR lineshapes to highly 
transient interactions, and illustrates the importance of establishing experimental 
conditions in which the specific interaction(s) of interest dominate the observed 
changes in lineshape. 
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CHAPTER 3 
THERMODYNAMICS OF THE INTERACTION OF PIN1-WW 
DOMAIN AND PHOSPHORYLATED APP CYTOPLASMIC TAIL 
*
 
 
Introduction 
Isothermal titration calorimetry (ITC) was discovered almost 45 years ago 
(Christensen et al., 1966) and since has been the most favored technique to study 
thermodynamics of binding (Chaires, 2008).  Almost all chemical reactions or 
physical interactions such as protein-ligand binding are accompanied with a change in 
heat.  Since the calorimeter can monitor such change in heat, it can be viewed as a 
universal detector.  Modern day calorimeters can detect heat effects as small as 0.1 
μCal which allows the determination of binding affinities as large as 109 M-1 (Freyer 
and Lewis, 2008).  Even though ITC was first developed as a technique to 
simultaneously determine the binding-energetics, i.e. free energy (G), enthalpy (H) 
and entropy (S), from a single experiment, it has since been used to study kinetics, 
too (Todd and Gomez, 2001).  Modern ITC instruments are capable of determining the 
Michaelis-Menten constant (KM) and reaction rate (kcat) in the ranges of 10
-2
-10
3
 μM 
and 0.05-500 s
-1
, respectively (Freyer and Lewis, 2008). 
We used ITC to independently determine the binding constant (KD) of the 
pAICD derived peptide (pAPP659-682) to the isolated Pin1-WW domain and confirm 
the binding constant obtained from NMR lineshape analysis.  The use of isothermal 
titration calorimetry (ITC) experiments provided a complete thermodynamic 
description of the interaction between pAICD and Pin1-WW, including changes in 
enthalpy and entropy of the system.  Since the peptide exists in two isomeric states, cis  
__________________________ 
* Parts of this chapter are based on a manuscript submitted to Nature Chemical Biology. 
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and trans, and only the trans isomer binds significantly to the Pin1-WW domain 
(Figure 3.1), the existing binding models were not adequate to fit our ITC data.  We 
derived a new set of equations and implemented the fitting in matlab.  Monte-carlo 
simulations were used to estimate the errors in the fitting parameters. 
 
Figure 3.1:  The reaction scheme for interaction of pAICD and isolated Pin1-WW 
domain.  The kinetic (a) and thermodynamic (b) parameters for the isomerization and 
binding steps are shown. 
We were also able to determine the uncatalyzed, slow cis-trans isomerization 
rates of pT668-P669 peptide bond in pAICD from analysis of the time-dependence of 
isolated ITC peaks.  The determination of the slow isomerization rate, its speeding up 
in the presence of Pin1 (Pastorino et al., 2006) and the binding rate of an isomer-
specific interaction between trans pAICD and Pin1-WW domain, led us to 
hypothesize on Pin1‟s influence on isomer-specific interactions.  The two isomers 
have distinct structural features (Figure 3.2) and can potentially be recognized by 
isomer-specific binding partners in the cell.  An example of such isomer-specific 
interaction is the trans-specific dephosphorylation by the phosphatase PP2A (Zhou et 
al., 2000).  The interaction of the two isomers to their specific binding partners can 
signal different or even competing functions (Figure 3.2) in the cell such as the 
amyloidogenic and the non-amyloidogenic processing pathways of APP (Nicholson 
and Lu, 2007; Pastorino et al., 2006).  Here we show that the catalytic activity of Pin1 
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can modulate the effective binding affinity of the putative isomer-specific binding 
partners and thus, can regulate the isomer-specific signaling events.  In the absence of 
Pin1, the binding affinity of the isomer-specific interactions decreases in comparison 
to that in the presence of Pin1, when considered in a timescale of 1 to 10 seconds.  
Moreover, this effect is greater in the lesser populated isomer.  In summary, this 
provided us with a detailed description of the thermodynamics of Pin1-WW domain 
and pAICD interaction and the role of Pin1 as a modulator of the effective binding 
affinities of the isomer-specific binding partners. 
 
Materials and Methods 
Protein expression and purification 
Protein expression and purification for WW domain was carried out as 
described in the previous chapter.  Pin1 gene is encoded in a PGex expression vector 
with GST-tag and thrombin cleavage site between the tag and the protein and was 
generously provided by Dr. Kun Ping Lu, Harvard Medical School.  The protein was 
expressed in BL21 DE3 E. coli cells which were grown in 1L LB media at 37°C in the 
presence of 100µg/ml amphicillin.  The protein expression was induced with 1mM 
IPTG at O.D600 of 0.8 and harvested after 4 hours by centrifugation at 4920 g for 10 
min at 4°C.  
Pin1 purification was carried out at 4°C.  The cells were lysed in 20ml lysis 
buffer (25mM HEPES, 150mM NaCl, pH = 7.5) containing 8mg of EDTA, 1mM 
DTT, 20µM of PMSF, 20µl protease inhibitor cocktail and 20µg Lysozyme.  The 
lysed cells were sonicated on ice with 50% duty cycle for 5 min and the cell debris 
was removed by centrifugation for 40 min at 23,500 g.  The supernatant was filtered 
using 0.80μm filter and passed over a packed column of 2ml glutathione Sepharose 
4B(Amersham GE), pre-equilibrated with wash buffer (25mM HEPES, 150mM NaCl, 
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Figure 3.2:  Phosphorylation of T668 results in the emergence of trans and cis isomers 
of the pT668-P669 peptide bond which have distinct structural features.  Each isomer 
can be recognized by isomer-specific binding partners resulting in distinct cellular 
functions. 
 
pH = 7.5).  The column was washed with 10 bed volumes of wash buffer and 5 bed 
volumes of cleavage buffer (20mM Tris-HCl, 150mM NaCl, 2.5mM CaCl2, pH=8.4) 
leaving 1 bed volume of the cleavage buffer in the column.  The protease was 
prepared by adding 5µl thrombin to 95µl dilution buffer and all 100µl was added to 
the column.  The column was rocked slowly at room temperature for 16 hrs.  Cleaved 
Pin1 was collected by flowing out the buffer from the column.  Two more fractions 
were collected by washing the column with 2 bed volumes of wash buffer each.  The 3 
fractions were checked for protein by UV absorption at 280 nm and also by Bradford 
assay.  To remove thrombin 60µl streptavidin-agarose beads were added to the pooled 
fractions containing Pin1, rocked for 30 min and removed by spin columns.  The 
purified protein was dialyzed into the final buffer (10mM HEPES, 10mM NaCl, 1mM 
DTT, 5mM NaN3, pH = 6.9) overnight at 4°C.  
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Peptide Synthesis 
The purified phosphopeptide (pAPP659-682) was purchased from the Tufts 
University Core Facility, Boston.  It was weighed out, as required, dissolved in 200μl 
de-ionized H2O, adjusted to pH ~7 using NaOH and lyophilized.  The lyophilized 
peptide was dissolved in the final buffer.  The pH of the sample adjusts to the pH of 
the buffer.  The concentration is measured using tyrosine extinction coefficient of 
1400 M
-1
cm
-1
 (Creighton, 1993). 
Isothermal Titration Calorimetry (ITC) 
The titration experiments were performed in a Calorimetry Sciences Corp. 
(Lindon, UT) Nano-ITC Series III instrument at 25°C.  The protein and the peptide 
samples were degassed for 10 min prior to each experiment.  The reaction cell was 
filled with 1.4ml of protein (WW-domain or Pin1) and 100μl or 250μl syringe was 
used to titrate in the peptide.  For the WW domain:pAICD binding experiment, 170 
μM of protein and 4.3 mM of peptide was used.  The peptide was injected using the 
250μl syringe.  A total of 31 injections were made of 8μl each with an interval of 8 
min between injections.  The sample was stirred at 200rpm for rapid mixing.  The 
binding experiment was also done in the presence of catalytic amount of Pin1.  For 
this experiment 160μM of WW domain, 4.2μM of Pin1 and 4.3 mM of peptide was 
used.  A total of 41 injections were made with 6μl each with an interval of 5 min 
between injections.  To get the heat of dilution of the peptide, 4.3 mM peptide was 
injected into the sample buffer and the average heat of dilution was subtracted from 
the titration data.  For the kinetics experiment 250 μl of 0.65 mM TAR2 was titrated 
into 70 μM of WW domain.  Total 31 injections were made with 8 μl each.  The 
injections were made at an interval of 8 min to ensure the complete return of the signal 
to the baseline. 
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Derivation of expressions for the binding isotherm 
The following derivation is adapted from derivation of one-to-one binding by 
Lewis and Murphy (Lewis, 2005).  The heat evolved from each injection (qi) has two 
components: heat resulting from trans isomer binding to WW (qb,i) and heat resulting 
from the conversion of cis isomer to trans isomer (qct,i).  The heat of binding is given 
by the following expression 
                                                         
where          
      
        
,  
is the excess enthalpy per mole of macromolecule, KA is the binding constant, ΔHb is 
the binding enthalpy per mole and [T]i is the concentration of the free trans isomer.  
During the course of the experiment, the volume of solution that is ejected from the 
reaction cell equals the volume of ligand injected, which dilutes the concentration of 
the macromolecule as follows  
                     where the dilution factor is       
    
     
 
 
 
The concentration of the free trans isomer [T]i after each injection is calculated by 
solving the following set of equations 
                        ,       
    
    
,    
     
        
,                     
The heat of isomerization is given by the following expression 
           
       
     
 
           
       
 
    
     
       where Hct is the enthalpy of cis to 
trans conversion.  Thus, the total heat for injection „i‟ is given by  
qi = qb,i + qct,i           (3.1) 
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In the above equations [M]tot,i is the total concentration of the macromolecule after the 
i
th
 injection, Ltot,0 is the ligand concentration in the syringe, Vcell is the reaction cell 
volume, Vinj is the injection volume of the peptide, „n‟ is the number of binding sites 
in the protein, and Kisom is the free trans to cis equilibrium constant.  [T]i and [C]i are 
the concentrations of the free trans and cis isomers respectively. 
The fitting was performed in matlab.  The non-linear least squares fitting 
routine „lsqnonlin‟, available in matlab, was used to iteratively fit the ITC data to 
equation (3.1) and KA, ΔHb, ΔHct and n were the fitting parameters.  The errors in the 
fitted parameters were estimated using Monte-Carlo simulation.  Normally distributed 
random noise was added to the best-fit solution of the binding isotherm to generate 
1000 synthetic datasets which were then fit to equation (3.1) to get 1000 sets of fitted 
parameters.  The standard deviation of each parameter was reported as the error for 
that parameter.  Hereafter, “code” refers to matlab programs written in-house.  The 
iterative fitting routine is implemented in the code „ITCfit‟.  The code „myT‟ 
implements the analytical expression for the free trans isomer after each injection, 
„myQ_calc‟ calculates the heat evolved from each injection using equation (3.1) and 
„myQ‟ calculates the error between the experimental and calculated heats at each 
injection.  The Monte-Carlo simulation is implemented in the code 
„ShakeSimDataErrorEstimateMC‟. 
 
Derivation of approximate expressions for time-dependence 
After each injection, the trans isomer binds rapidly to the free WW domain in 
the reaction cell which is followed by the slow conversion of free cis to free trans and 
its subsequent binding (Figure 3.1a).  The time-dependence of each species i.e. free cis 
[C], free trans [T] and the bound WW domain [WW:T] can be expressed using 
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differential equations (3.2) which constitute a set of coupled non-linear ordinary 
differential equations (ODEs). 
    
  
                      (3.2a) 
    
  
                                             (3.2b) 
       
  
                                  (3.2c) 
where kAB and kBA are the rates for cis to trans and trans to cis conversion 
respectively, kBC and kCB are the on and off rates respectively and [WW0] is the 
concentration of the total WW domain.  The set of coupled ordinary differential 
equations (3.2) were numerically solved and plotted (Figure 3.3a).  For the numerical 
solution, the parameter values used are kAB = 0.01 s
-1
, kBA = 0.001 s
-1
, kBC = 2220 s
-1
 
and kCB = 6.3×10
7
 s
-1
.  From the plots it is clear that the binding of the trans isomer to 
WW domain is complete within the first few milliseconds.  Then the system 
equilibrates according to the slow cis to trans conversion rate (Figure 3.3b).  Since the 
time-dependence of the cis isomer, equation (3.2a), is only dependent on the rates kAB 
and kBA and not on the fast binding kinetics (kBC and kCB), an approximate expression 
for its time dependence can be obtained by neglecting the binding step and solving the 
resulting equations (3.3). 
    
  
                      (3.3a) 
    
  
                     (3.3b) 
            
   
   
        
     
       
                 (3.4) 
The resulting time-dependence of the cis isomer is given by equation (3.4) which 
represents an exponential decay, where [Ceq] is its final equilibrium concentration.  In 
comparison to the time-course obtained from the numerically solved ODEs,  the 
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analytical equation (3.4) represents the time-dependence of the cis isomer very well 
(Figure 3.3 c and d).  After the initial fast binding, there is no appreciable cis to trans 
conversion and the free trans and the bound trans reach a pseudo-equilibrium state 
with concentrations [Teq
0
] and [WW:Teq
0
], respectively (Figure 3.3a).  These pseudo-
equilibrium concentrations were solved from the equations (3.5).  Equation (3.5a) 
represents the steady-state condition, equation (3.5b) is the total trans concentration 
which excludes the cis isomer of the peptide that was initially present and equation 
(3.5c) is the total WW domain concentration. 
     
  
  
         
       
             
        (3.5a) 
    
          
   
       
       
       (3.5b) 
     
          
              (3.5c) 
where [L0] and [WW0] are the total concentrations of the peptide and the WW domain, 
respectively.  Similar to the free cis isomer, the slow relaxation of the free trans and 
the bound WW domain from [Teq
0
] and [WW:Teq
0
] to [Teq] and [WW:Teq], 
respectively, should also be exponential decaying functions.  Hence, their time-
dependence can be modeled by equations (3.6a) and (3.6b). 
                         
                    (3.6a) 
                                     
                 (3.6b) 
The equations (3.4) and (3.6) model the time-dependence of the free cis, free trans and 
bound WW domain concentrations very well in the post-fast binding period (Figure 
3.3 c and d).  The expression for the time-dependence of the cis isomer, equation (3.4), 
was obtained by neglecting the kinetics of the fast binding step, only treating it as a 
step that removes the trans isomer.  The resulting expression is in excellent agreement  
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Figure 3.3:  Approximate analytical expressions accurately predict the time-
dependence for the free cis, free trans and bound trans species.  a)  Numerical solution 
of ODEs in equation 3.3 solving for the free cis (red), free trans (blue) and bound 
trans (green) is plotted.  The plot of the first 10 milliseconds shows that the binding 
step is very fast and is complete in this time-scale.  b)  The system reaches equilibrium 
slowly due to the slow isomerization step.  Beyond the first few milliseconds, the 
time-dependence of the three species behaves similarly.  c)  The approximate time-
dependence for the three species, given by the equations (3.4) and (3.5), are plotted as 
broken brown lines.  The approximate equations match the actual solutions very well.  
d)  The approximate solution for the cis isomer matches its actual solution (solid red) 
even in the first few milliseconds.  The approximate solutions for other two species 
match their actual solutions once the fast binding is complete (i.e. after ~0.6 ms). 
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to the actual time-dependence of the cis isomer of the entire time-period (Figure 3.3 c 
and d).  After each injection, the heat (q) released during the slow equilibration period, 
which is considered to be after several seconds of the injection when the fast binding 
is complete, can be modeled by equation (3.7) where the first part is the heat of 
isomerization and the second part is the heat of binding. 
  
  
            
    
  
           
       
  
          (3.7) 
In the above equation, -d[C]/dt is the rate of depletion of the free cis isomer, 
d[WW:T]/dt is the rate of formation of the bound WW domain, Vcell is the volume of 
the reaction cell and Hct and Hb are the enthalpies of cis to trans conversion and 
trans binding, respectively.  The corresponding rates are obtained by differentiating 
equations (3.4) and (3.6b) and are given as 
 
    
  
  
     
       
                 
               (3.8a) 
 
       
  
                
             
              (3.8b) 
Since the time-dependence is only in the exponent, equation (3.8) can be simplified as 
follows, 
  
  
                      (3.9) 
where kex = kAB + kBA.  From the ratio of the volumes of peaks corresponding to the 
cis and trans isomers in the 
15
N-
1
H HSQC spectrum of the 
15
N-labeled peptide, we 
obtained Kisom = Vtrans/Vcis = 14. 
   
   
               (3.10) 
The rates of isomerization, kAB and kBA, were obtained by fitting the ITC data to 
equations (3.9) and (3.10). 
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The kinetic-analysis of the ITC data was performed on the signals from the 4
th
 
injection to 10
th
 injection.  To extract out the slow decaying portion of the isothermal 
signal, the starting 2.5 minutes of the data were ignored and the rest was fit to equation 
(3.9).  Binding isotherms for interactions that do not involve a slow step are typically 
back to near-baseline after 2.5 min, indicating the thermal time-constant of the 
instrument is shorter than this.  The standard deviations in kAB and kBA obtained from 
the seven peaks were reported as errors of those parameters. 
The ordinary differential equations were numerically solved in matlab using 
the solver „ode15s‟.  Chemical reactions often result in stiff ode, i.e. the step size taken 
during the numerical solution should be extremely small and the solver „ode15s‟ in 
matlab is well suited to handle such problems.  The cis isomer-specific binding is 
simulated using the code „IsoBind_CisSpecific.m‟ and the differential equations are 
implemented in the code „IsoBindfunc_CisSpecific.m'.  Both codes are generated in-
house. 
 
Results 
Thermodynamics of binding and isomerization 
Isothermal titration calorimetry (ITC) was performed to determine the 
thermodynamic parameters such as the binding constant (KD), enthalpy (H) and 
entropy (S) of binding of (pAPP659-682) to the WW domain.  Since the binding 
reaction scheme (Figure 3.1b) involves isomerization and binding, the enthalpic 
contributions from both steps need to be considered.  Upon injection of the peptide 
into the isolated WW domain exothermic peaks were observed (Figure 3.4a) which 
returned to the baseline very slowly, displaying a slow exponential decay (Figure 
3.4b).  The initial part of the peak corresponds to the fast binding of the free trans 
isomer to the WW domain and results in the depletion of free trans.  The slow decay 
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results from the conversion of free cis to free trans isomer of the peptide and 
subsequent fast binding of the trans isomer to the WW domain.  Based on this 
observation, equation (3.1) was derived to represent the binding isotherm.  The 
binding isotherm data from the ITC experiment was fit to equation (3.1) (Figure 3.4c) 
to extract the binding constant (KD), binding enthalpy (Hb) and entropy (Sb) and 
also isomerization enthalpy (Hct) and entropy (Sct). 
The fitting yielded KD = 27 ± 2 μM, Hb = -41 ± 2kJ/mol, Hct = -43 ± 8 
kJ/mol and n = 0.95 ± 0.03, where errors are standard deviations obtained from 
Monte-Carlo simulations.  The corresponding entropies for binding and isomerization 
are TSb = -14.9 kJ/mol and TSct = -36.5 kJ/mol respectively.  The binding of the 
peptide to the WW domain is enthalpy driven, which is expected from the 
considerable electrostatic interactions in the interface.  The cis to trans conversion is 
also enthalpy driven. 
In order to confirm that the slow decay of the ITC signal (Figure 3.4b) is 
indeed due to the slow cis to trans isomerization, we did the same binding experiment 
in the presence of a catalytic amount of Pin1.  Upon titration, similar exothermic peaks 
were observed (Figure 3.5a).  The isolated peaks of the ITC binding experiments in 
the presence and absence of catalytic Pin1 were compared (Figure 3.5b and c).  The 
ITC peak in the presence of catalytic Pin1 is almost four fold larger but still returns to 
the baseline much quicker.  This convincingly demonstrates that the slow decay of the 
ITC signal is indeed due to the slow cis to trans isomerization. 
 
Kinetics of isomerization 
Apart from thermodynamic information, the ITC data also contains kinetic 
information (Fanghanel et al., 2006).  The exponentially decaying portion of the peaks 
4 to 10, in the raw ITC data, were extracted out and fit to equation (3.9) (Figure 3.6).   
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Figure 3.4:  ITC experiment of pAICD and isolated WW binding  a)  Raw data of the 
binding isotherm of the interaction of pAICD and isolated WW domain.  b)  Peaks in 
this isotherm return slowly to the baseline due to the heat released from the slow 
isomerization of free cis to free trans isomer.  c)  Fitting of the heat evolved from each 
injection to equation (3.1) using in-house matlab codes.  The enthalpy and entropy of 
both binding and isomerization were extracted from this fitting. 
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Figure 3.5:  Interaction of pAICD and isolated WW domain in the presence of a 
catalytic amount of Pin1  a)  Raw data for the binding isotherm from the ITC 
experiment performed to study the interaction of pAICD and WW domain in the 
presence of a catalytic amount of Pin1.  b)  Typical shape of an isolated peak in the 
above isotherm.  The largest peak has been selected for display here.  c)  Isolated peak 
from an experiment without any Pin1.  Comparison of b) and c) shows the faster 
return of the signal to baseline in the presence of catalytic amount of Pin1. 
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Figure 3.6:  Fitting (broken line) of the slow conversion of cis to trans isomer to 
equation (3.9). 
 
From the fitting we obtained kAB = 0.0089 ± 0.0013s
-1
 (mean ± standard deviation) 
and kBA = 0.00064 ± 0.0001s
-1
 which are in the same range as reported for other 
pSer/Thr-Pro peptides (Schutkowski et al., 1998).  Thus, from the ITC and NMR 
experiments, the complete kinetics of the isomerization and binding reactions of the 
pAICD:WW interaction is now determined. 
 
Pin1 as a connector and flux modulator 
The kinetics from the ITC and NMR data clearly show the difference in the 
timescales of the uncatalyzed cis-trans isomerization (kex = 0.00954 s
-1
) and the 
isomer-specific binding event (koff = 2220 s
-1
).  A catalytic amount of Pin1 increases 
the rate of isomerization (Pastorino et al., 2006) to kex
cat
 = 18 s
-1
, a 2000 fold 
acceleration.  In order to illustrate the effect of these different timescales on a protein 
interaction network, the smallest network with isomer-specific interactions is 
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considered (Figure 3.7a).  In this network, cis and trans isomers of a phosphorylated 
Pin1 substrate have isomer-specific binding partners P and Q, respectively.  In reality, 
there might be multiple isomer-specific binding partners with further downstream 
interactions but for illustrative purposes we will consider the simplest case of one 
binding partner for each isomer.  We predict that the effect of Pin1 on coupling cis and 
trans-specific networks will be more pronounced if cis (less-populated) isomer has 
higher affinity or more abundant binding partners as shown here.  For illustrative 
purposes, we assume the concentrations of the substrate (cis + trans) and the binding 
partners to be 1 μM each (reasonable cellular concentrations), the on-rates for both 
interactions to be 2×10
8
 M
-1
s
-1
 (diffusion limited), the dissociation constants for the cis 
and trans-specific binding partners to be 10 nM and 100 nM (dissociation constants < 
cellular concentrations) and the corresponding off-rates to be 2 s
-1
 and 20 s
-1
 for cis 
and trans isomers, respectively.  Initially, the free isomers are at equilibrium which is 
disturbed by the appearance of the binding partners, P and Q.  The time-dependence of 
the concentrations of the four species i.e. free cis (pC), free trans (pT), bound cis 
(pC:P) and bound trans (pT:Q) are given by equations (3.11): 
     
  
                       
                   
         (3.11a) 
     
  
                              
           
         (3.11b) 
       
  
                 
          
           (3.11c) 
       
  
                 
          
           (3.11d) 
where kct and ktc are the cis-trans inter-conversion rate constants, P0 and Q0 are the 
total concentrations of the binding partners and k
i
on and k
i
off are the on and off rate 
constants for the i
th
 isomer (i = cis or trans) (Figure 3.7a).  The concentrations of the 
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four species are obtained from the numerical solution of equations (3.11).  In the 
absence of Pin1, kct = 0.0089 s
-1
, ktc = 0.00064 s
-1
 and the time-dependence of the 
concentrations are given by the solid lines while, in the presence of Pin1, kct = 16.8 s
-1
, 
ktc = 1.2 s
-1
 and the time-dependence of the concentrations are given by the broken 
lines Figure 3.7b, c).  The fast binding of the isomers to the respective binding 
partners is complete within one second irrespective of whether Pin1 is present Figure 
3.7b).  The system then re-equilibrates according to the isomerization rates (Figure 
3.7c).  The fast and slow phases in the simulation clearly demonstrate the significantly 
different timescales of these two processes i.e. binding and isomerization.  The 
catalytic enhancement by Pin1 has significant impact on the equilibration of this 
smallest network.  In the timescale of 10 seconds, the slow phase reaches equilibrium 
only in the presence of Pin1 as evident from the time-dependence of bound cis (pC:P, 
magenta) and bound trans (pT:Q, cyan).  Thus, in the absence of Pin1, the isomer-
specific interactions are insulated from each other (dotted boxes Figure 3.7a) in this 
timescale, whereas they are connected and form a single network module in the 
presence of Pin1 (solid box, Figure 3.7a).   Pin1 activity also modulates the flux 
through the two isomer-specific network modules when the two bound species (pT:Q 
and pC:P) are the entry points into these distinct modules.  After 10 seconds, the 
population of pT:Q is 10.3 fold that of pC:P in the absence of Pin1 whereas they are 
almost equal in the presence of Pin1 (Figure 3.7c).  Hence, the effect of Pin1 activity 
on the protein interaction networks is more pronounced when the less populated 
isomer (cis) has higher affinity or more abundant interaction partners to compensate 
for the lower isomer population.  It is important to note that the time-scale on the order 
of a few seconds is relevant, since cellular signaling activities, such as active or 
passive cellular diffusion, kinase or phosphatase reactions, or protein conformational 
changes, occur within this timescale (Papin et al., 2005).   
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From the above analysis, it is evident that upon appearance of binding partners 
P and Q there is no effective inter-conversion of the isomers in the absence of Pin1 in 
the short timescale, whereas re-equilibration to the new conditions is effectively 
complete in the presence of Pin1.  Since the amount of bound species is different in 
the presence and absence of Pin1, it is informative to express the binding reactions in  
terms of effective dissociation constants (KD,eff) for these two cases, where we assume 
that there is no inter-conversion of the isomers in the absence and complete inter-
conversion in the presence of Pin1 in the timescale of few seconds.  The effective 
dissociation constants for the cis and the trans isomer-specific binding partners in the 
absence of Pin1 is given by  
      
      
                          (3.12a) 
      
        
        
 
     
  
   
     
      (3.12b) 
where KD
cis
 and KD
trans
 are the intrinsic dissociation constants for the cis and the trans 
isomers, respectively, Kisom (= [T]free/[C]free) is the equilibrium constant of the free 
trans and cis isomers, and [P] and [Q] are the concentrations of the free isomer-
specific binding partners.  The effective dissociation constants in the presence of Pin1 
are 
      
      
                   (3.13a) 
      
        
        
 
     
         (3.13b) 
As discussed above, these expressions show that the effective dissociation constant for 
the isomer-specific binding partners increases in the absence of Pin1 (Figure 3.7d).  
Interestingly, this effect is more severe for the less-populated isomer (cis) and 
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Figure 3.7  Modulation of network connection and flux by Pin1.  (a)  The 
phosphorylated cis and trans isomers undergo isomerization and also bind to isomer-
specific binding partners P and Q, respectively.  The bound species pcis:P and 
ptrans:Q are the entry points to the two networks.  The filled circles represent nodes 
and the lines represent connections in the networks.  In the absence of Pin1, the two 
network modules (dotted box) are insulated from each other.  In the presence of Pin1, 
the two modules are connected and act as a single module (solid box).  (b)  First 100 
milliseconds of the time-dependence of free cis (red), free trans (blue), bound cis 
(magenta) and bound trans (cyan) in the presence (dotted lines) and absence (solid 
lines) of Pin1.  (c)  First 10 seconds of the time-dependence.  The difference in the 
population of the bound species pcis:P and ptrans:Q in the presence and absence of 
Pin1 activity are shown by arrows.  (d)  Dependence of the effective dissociation 
constant for the cis isomer on the equilibrium constant (Kisom) in the presence and 
absence of Pin1.  The dotted line is for pAICD, Kisom = 14.  (e)  The effect of the Kisom 
on the effective binding constant is more pronounced on the less populated isomer. 
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increases as a function of the equilibrium constant (Kisom) (Figure 3.7e).  Thus, the 
catalytic activity of Pin1 can also dramatically modulate the effective dissociation 
constant of the isomer-specific binding partners in the relevant timescale of a signaling 
event, especially for the lower populated (cis) isomer. 
 
Discussion 
An emerging role of the prolyl cis-trans isomerization is that of a molecular 
timer where each isomer is associated with two distinct functions of the protein.  For 
example, in the adaptor protein Crk, prolyl isomerization is involved in autoinhibition, 
where the cis conformation inhibits ligand binding (Sarkar et al., 2007).  Another 
example is the prolyl isomerization driven activation of the filamentous phage fd 
infection of Escherichia coli cells (Eckert et al., 2005).  PPIases can modulate these 
timers by tuning the lifetime of each isomer.  Here we report the intrinsic, uncatalyzed 
exchange rate of the isomers in T668-phosphorylated APP as 0.0095 s
-1
 with the 
lifetime of the cis and the trans isomers being 2 min and 26 min, respectively.  The 
peptidyl prolyl isomerase Pin1 speeds up this process 2000 fold (Pastorino et al., 
2006) and thus, decreases the corresponding lifetimes to 60 ms and 0.5 s, respectively.  
The lifetimes of each isomer become relevant in the presence of isomer-specific 
interaction partners.  For example, proline directed phosphatases are trans specific 
(Hamdane et al., 2006; Zhou et al., 2000) and the cis isomer is dephosphorylated only 
via its isomerization to trans.  Thus, in the absence of Pin1 the phosphorylated cis 
isomer will be long-lived and have a higher probability of interacting with its binding 
partners, whereas the trans isomer will be rapidly depleted by phosphatases.  Such 
tuning of the cis-trans molecular timer by Pin1 might be one of the key mechanisms 
by which it can influence various signaling pathways. 
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The results presented here show that the intrinsic, uncatalyzed isomerization 
rates (<0.01 s
-1
) are very slow relative to the binding rates (kon×[free protein] > 100 s
-
1
).  These vastly different timescales have significant functional implications for 
protein-protein interaction networks that include isomer-specific binding partners, 
comprising a fundamental molecular switch that acts as a “circuit breaker”, which is 
“open” in the absence and “closed” in the presence of Pin1 activity.  In such networks 
the relative timescales of various events should be comparable to each other; 
otherwise the events with significantly different timescales would have no effective 
interaction (Papin et al., 2005).  We have derived the mathematical framework for 
simulating the impact of cis-trans isomerization rates on two network modules that 
involve different isomer-specific interactions, one for cis and one for trans isomer.  
Without PPIase activity such network modules are insulated from each other on short 
timescales (<10 s), but are effectively coupled and modulated on this timescale when 
PPIase activity is present. 
The addition of phosphorylation as a specificity determinant in the pS/T-P cis-
trans molecular timer motif provides an additional level of regulation that is mediated 
by the temporally separated, competing activities of trans-specific (Brown et al., 1999; 
Weiwad et al., 2000) kinase and phosphatase enzymes.  During the cell cycle, kinase 
and phosphatase activities must be separated into different periods, typically tens of 
minutes long (Novak et al., 2010).  This temporal separation provides a mechanism by 
which the phosphorylated cis isomer can be produced during the kinase-active period, 
independent of Pin1 activity.  However, in the absence of Pin1 activity, the 
connectivity between isomer-specific networks is lost (Figure 3.8a).  The flux through 
the trans-specific network is higher but is rapidly shut-down due to trans-specific 
dephosphorylation during the phosphatase-active period, whereas the relatively lower 
flux in the cis-specific network persist much longer (Figure 3.8b).  Thus, in the 
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Figure 3.8  Effect of Pin1 catalysis on modular architecture of interaction networks.  
(a)  The S/T-P motif is phosphorylated by proline directed kinases to generate 
phosphorylated trans isomer (ptrans) which isomerizes to cis isomer (pcis).  The 
unphosphorylated and phosphorylated forms might have their own protein interaction 
networks.  In the absence of Pin1 the isomer-specific networks are insulated modules 
(dotted box) while in its presence they form a single network module (solid box).  In 
the absence of Pin1 trans-specific phosphatase activity results in two network modules 
(dotted box) while in its presence (solid box) the cis-specific interaction network is 
also rapidly shut-down.  (b)  Time-dependence of free S/T-P (green), free cis (red), 
free trans (blue), bound cis (magenta) and bound trans (cyan) in the presence (dotted 
lines) and absence (solid lines) of Pin1.  The trans-specific kinases are assumed to be 
active for the first 20 minutes while the trans-specific phosphatases are active for the 
next 100 minutes.  The cis-specific interaction network module persists for the entire 
phosphatase active period in the absence of Pin1, while the trans-specific network 
module shuts down rapidly. 
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absence of Pin1 activity the cis-specific network is “on” for the entire phosphatase-
active period while the competing trans-specific network is turned “off”.  In the 
presence of Pin1 activity, the isomer-specific networks are connected and might have 
distinct function as compared to the disconnected networks.  During the phosphatase 
active period, the connected networks are simultaneously turned “off”.  Thus, the cis-
specific network only becomes dominant in the absence of Pin1 activity and during the 
phosphatase active period.  This illustrates the impact of the combined regulatory 
effects of kinases, phosphatases, and Pin1 on the modular architecture of protein 
interaction networks that might result in distinct functional modules of a cell.  Such 
modulation of isomer-specific interaction networks by Pin1 might be one of the key 
mechanisms by which it can influence various signaling pathways.  These results offer 
for the first time a direct molecular mechanism to explain why the catalytic activity of 
Pin1 is necessary for its essential function in yeast (Zhou et al., 2000) or in all other 
Pin1-related functions identified so far (Nicholson and Lu, 2007). 
In conclusion, these studies and analyses predict a powerful and novel role of 
Pin1 in coupling protein interaction network modules, modulating flux through them 
and also modulating the effective binding affinities of the isomer-specific binding 
partners.  Thus, Pin1 activity can alter the modular architecture of the isomer-specific 
interaction networks and thereby explain its profound impact on biological and 
pathological processes.  The challenge now is to identify such isomer-specific 
interaction networks for biological substrates of Pin1, such as APP phosphorylated at 
T668. 
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CHAPTER 4 
DESIGN OF NOVEL PROBES TO STUDY ISOMER-SPECIFIC 
BINDING INTERACTIONS 
 
The APP intracellular domain (AICD) plays important roles in APP trafficking 
(Sannerud and Annaert, 2009), APP processing (De Strooper and Annaert, 2000) and 
transcription of genes that are important in APP trafficking, phosphorylation and 
processing (Muller et al., 2008).  Its function is also modulated by phosphorylation 
(Lee et al., 2003b).  AICD has eight potential phosphorylation sites, of which, T668 
phosphorylation has the most impact on its structure (Ramelot and Nicholson, 2001) 
and function (Lee et al., 2003b).  Phosphorylation of T668 results in the emergence of 
cis and trans isomers, which have distinct structural features (Figure 1.2a).  Even 
though the phosphorylation of T668 has been shown as an important event in AD, the 
distinct functional roles played by unphosphorylated AICD, cis pAICD and trans 
pAICD are not well understood (Pastorino et al., 2006).  Moreover, the roles of these 
three species would also depend on two scenarios: AICD is in the full-length APP or 
AICD is a product of the γ-secretase processing.  As part of full-length APP, AICD 
directs its trafficking and localization in the cell (Sannerud and Annaert, 2009), which 
in turn dictates the APP-processing pathway.  On the other hand, as a proteolytic 
cleavage product, AICD binds to various cellular partners, is translocated into the 
nucleus and promotes transcription of certain genes (Muller et al., 2008).  Deciphering 
the distinct roles played by the three AICD species would go a long way in 
illuminating the molecular mechanism of AD and provide us with specific therapeutic 
targets. 
As discussed in Chapter 1, we hypothesized that the cis pAICD interacts with 
its specific binding partners and enhances the trafficking of APP into the endocytic 
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pathway.  Moreover, isomer-specific interactions in the nucleus might also result in 
transcription of different sets of genes by the two isomers which might favor one or 
the other APP processing pathway.  In order to investigate these possibilities, we aim 
to identify the pAICD isomer-specific binding partners in the cell.  Such binding 
partners might be involved in secretory pathways, endocytic pathways, nuclear 
transport and gene transcription complexes.  Their identification would enable us to 
investigate our hypothesis that the cis isomer of pAICD favors amyloidogenic 
processing of APP.  The potential outcome of these studies is the identification of 
human proteins that bind specifically to the phospho-T668 form of the APP 
cytoplasmic tail, and the validation of one or more of these proteins as a therapeutic 
target in Alzheimer‟s disease. 
 
 
 
Figure 4.1:  Structures of the cis and trans isomers of the VpTPE sequence in pAICD 
phosphorylated at T668.  The H-bonds in each isomer are shown as dashed lines.  The 
two isomers have distinct structural features. 
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Our hypothesis regarding the potential role of the cis and trans isomers of 
pAICD centers on putative isomer-specific recognition events.  Since the two isomeric 
states are chemically identical, prior work such as proteomics studies would not have 
detected isomer specificity.  Identification of such isomer-specific interactions would 
require molecular probes trapped in an isomeric state or inhibitors for isomer-specific 
binding partners.  Since the cis and trans isomers isomerize quickly (within tens of 
minutes), their separation from each other is not possible.  This makes it necessary to 
design mimics for each isomer.  We utilized several strategies to design cis and trans 
isomer mimics. We also designed molecular probes and “fishing experiments” that 
would enable us to identify the isomer-specific binding partners in the cell. 
 
Cyclic peptide based on pAICD sequence as a cis isomer mimic 
A cis enriched cyclic peptide was designed and synthesized based on the cis 
pAICD NMR structure (Figure 4.1).  The distinctive features of the cis isomer as 
compared to the trans are: 
1. Different hydrogen bonding patterns. 
2. More extended backbone conformation in the cis isomeric state, aside 
from the kink of the peptide bond. 
3. Presence of hydrogen bonding between V667 amide NH and E670 
sidechain. 
We reasoned that the cis isomer could be stabilized by forming a covalent bond 
between V667 amine NH2 and E670 sidechain COOH.  For this purpose, we used a six 
amino acid residue peptide with the sequence V667-pT-P-E-E-R672 derived from 
pAICD.  A peptide bond between V667 amine NH2 and E670 sidechain COOH was 
formed which increased the cis population. 
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Figure 4.2:  a)  Overlay of the phosphorylated cyclic dipeptide (pCDP) structure with 
structures of cis and trans isomers of pAICD.  The pCDP backbone fits well to that of 
the cis isomer.  b)  Structure of the cis isomer of pAICD with the proposed covalent 
bond that would lock it in the cis conformation.  c)  The structure space of pCDP 
showing the four different dimensions that can be varied to generate a library of 
compounds based on pCDP.  d)  Comparison of the sidechains of alanine, proline and 
valine residues.  The proline residue is replaced with alanine or valine in the pAICD 
sequence to design trans-locked peptides. 
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Cyclic dipeptide as a cis isomer mimic 
The cis isomer is well-mimicked in nature by proline containing cyclic 
dipeptides.  The diketopiperazine core structure of these cyclic dipeptides overlay well 
with the cis conformer (Figure 4.2a).  Cyclic dipeptides (CDP) are ubiquitous in nature 
and exhibit varied biological activities in mammals (Prasad, 1995).  The CDP 
cycloHis-Pro has been shown to have biological activities involving endocrine, 
autonomic, analeptic and central nervous systems.  Levels of cycloHis-Pro were found 
to be elevated in a group of patients diagnosed with various 
neurological/neuropsychiatric disorders (Wisniewski et al., 1994).  The CDP 
cycloPhe-Pro has been shown to inhibit cancer cell growth and inhibit apoptosis 
(Brauns et al., 2004).  A novel CDP 1-ARA-35b was shown to enhance motor and 
cognitive recovery after traumatic brain injury in rats and also showed neuroprotection 
(Faden et al., 2003).  These are a few interesting examples of the diverse activities 
shown by the CDPs.  Thus, the cis mimicking core structure of CDPs is well 
recognized by different biological pathways. 
The phosphorylated Thr-Pro (pT-P) cyclic dipeptide should mimic the known 
structure of the cis isomer of the –pTPEERH– motif in the cytoplasmic tail of APP 
(Ramelot and Nicholson, 2001).  The key feature of the cis isomer that is distinct from 
the structure of the trans isomer is the close proximity of the amide NH of T668 and 
CO of P669 which are within a bond-forming distance (Figure 4.2b).  Closure of the 
pT-P backbone atoms to form a 6-membered ring is accomplished by addition of a 
second peptide bond which locks the pT-P into the cis conformation (Figure 4.2b).  
The resulting 5, 6-membered double-ring phosphorylated cyclic dipeptide (pCDP) 
(Figure 4.2c) is completely trapped in the cis conformation.  It is important to note that 
this small molecule is a substrate analogue for Pin1, since it mimics the cis isomer of 
pAICD.  Hence, it should not bind the enzyme tightly.  Enzymes evolve to bind the 
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transition state of a reaction most tightly and bind the substrates and the products 
weakly.  Accordingly, we expect that pCDP should have very weak affinity for Pin1.  
Since the WW domain of Pin1 does not interact with cis isomer, pCDP should interact 
only with the PPIase domain of Pin1.  On the other hand, we expect much tighter 
interaction of pCDP with the cellular binding partners that specifically recognize the 
cis isomer of pAICD. 
 
Modifications of pCDP for efficient cellular uptake 
Phosphorylated compounds are not effective in penetrating the cell wall due to 
the negative charges on the phosphate group.  Hence, for the efficient uptake of such 
compound by cells the phosphate group needs to be protected.  The protecting group 
bis-pivaloyl-oxymethyl (bisPOM) has been found to be particularly effective in 
delivering phosphorylated drugs into cells (Rutschow et al., 2002).  Once inside the 
cell the bisPOM group is removed by esterases resulting in the active phosphorylated 
compound.  Thus, one strategy for delivering pCDP into the cell would be to protect 
the phosphate group with bisPOM group. 
Another strategy to deliver pCDP into the cell is by coupling it to the TAT-tag 
(Brooks et al., 2005).  The HIV-TAT derived peptide is a small basic peptide that has 
been efficiently used to deliver molecules of various sizes (small compounds to 
proteins and nucleic acids) into the cell.  The TAT-tag contains a stretch of nine basic 
residues with the sequence RKKRRQRRR.  In order to attach other residues, such as 
the TAT-tag, to pCDP it is necessary to attach a linker (Figure 4.2c) to this compound.  
The important feature of this linker is the presence of a carboxyl group, which would 
enable the use of this molecule in solid-phase peptide synthesis to add to any peptide 
sequence as the N-terminal residue.  The attachment of the linker would also enable 
the use of pCDP as a bait to identify cis isomer-specific binding partners in the cell. 
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Cyclic dipeptide as an inhibitor 
The pCDP compound mimicking the cis conformation of APP can also be used 
as a lead compound for designing inhibitors, which would specifically block the 
activity of the cis-isomer specific binding partners and thus, the amyloidogenic APP 
processing pathway.  Exploration of the structure space of pCDP using these 
compounds should provide us with a library of compounds that can be screened for 
subsequent drug development for the prevention and treatment of Alzheimer‟s disease.  
The proposed compounds and variations thereof are described in a pending US Patent 
Application (US20080058276_A1) and in a recent Invention Disclosure (D-4784, 
Cornell Center for Technology, Enterprise & Commercialization).  The core structure 
of the phosphorylated cyclic dipeptide (pCDP) features four major structural elements 
(Figure 4.2c).  Each of these features can be varied to achieve optimal binding of the 
dipeptide to its target, corresponding to variation of pCDP along four dimensions in 
structure space.  With regard to structure-activity relationships (SAR), the four 
dimensions are: C-terminus, diketopiperazine ring, proline ring and the phosphate 
moiety.  A few representative examples of the variation of the structure space of pCDP 
are shown in Table 4.1.  Various peptide sequences can be added to the C-terminus of 
pCDP such as the minimal AICD sequence ERH (compound 1, Table 1), GRH 
(positive charges on R and H would neutralize the negatively charged phosphate, 2), 
positively charged primary amine (3), tertiary amine (4) and TAT tag (Brooks et al., 
2005) following the minimal AICD sequence which could also assist cellular uptake 
(5).  The positive charge at the C-terminus on compounds 2, 3 and 4 are designed to 
counter the negative charges of the phosphate group, which may facilitate uptake of 
these molecules by the cell. 
The second dimension of structural variation concerns the diketopiperazine 
moiety (Figure 4.2c).  The diketopiperazine ring is rich in heteroatoms and changing 
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Table 4.1:  Variations of pCDP structure 
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achieve optimal binding of the dipeptide to its target, corresponding to variation of 
pCDP along four dimensions in structure space.  With regard to structure-activity 
relationships (SAR), the four dimensions are: C-terminus, diketopiperazine ring, 
proline ring and the phosphate moiety.  A few representative examples of the variation 
of the structure space of pCDP are shown in Table 4.1.  Various peptide sequences can 
be added to the C-terminus of pCDP such as the minimal AICD sequence ERH 
(compound 1, Table 1), GRH (positive charges on R and H would neutralize the 
negatively charged phosphate, 2), positively charged primary amine (3), tertiary amine 
(4) and TAT tag (Brooks et al., 2005) following the minimal AICD sequence which 
could also assist cellular uptake (5).  The positive charge at the C-terminus on 
compounds 2, 3 and 4 are designed to counter the negative charges of the phosphate 
group, which may facilitate uptake of these molecules by the cell. 
The second dimension of structural variation concerns the diketopiperazine 
moiety (Figure 4.2c).  The diketopiperazine ring is rich in heteroatoms and changing 
this ring structure will place them in different orientation, thus, exploring the hydrogen 
bonding possibilities with the target.  The six-member diketopiperazine ring can be 
expanded to a seven or eight-member ring by including -amino acids (5 and 6).  The 
third structural feature that can be optimized is represented by the backbone of the 
proline ring.  In the design of Pin1 inhibitors, it has been observed that increasing the 
5-membered ring to a 6-membered ring increases the affinity of the substrate to the 
enzyme (Zhang et al., 2007).  Variations in this structure space can be made by using 
four (9), five (7), six (8) member rings, dimethyl-proline, fluoro-proline and 
unsaturated proline.  Finally, the fourth dimension of structural variation is the 
threonine sidechain and the phosphate group.  Variations include Glu (10) or Ser 
instead of Thr, sulfate (11) instead of phosphate and phosphate group protected by bis-
pivaloyloxymethyl (POM) groups (12) (Hwang and Cole, 2004).  An exhaustive 
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combination of these variations will give us a library of 5×4×6×4 i.e. 480 compounds 
based on pCDP. 
 
Design of trans-locked peptides 
As discussed in chapter 2, the TPEE region in unphosphorylated AICD forms a 
transient helix capping box structure which stabilizes the trans isomer (Ramelot and 
Nicholson, 2001).  Upon phosphorylation the helix capping box structure is disrupted 
resulting in the emergence of cis isomer (~ 7%) along with the trans isomer.  The cis-
peptide bond has much higher free energy as compared to the trans peptide bond due 
to steric hindrance.  In Xxx-Pro peptide bond, the trans isomer is relatively 
destabilized resulting in an appreciable amount of cis isomer.  Hence, mutating P669 
in pAICD should stabilize the trans isomer resulting in ~ 100% trans peptide.  The 
proline residue was mutated to Ala or Val (Figure 4.2d) resulting in trans locked 
peptides trans-locked A or trans-locked B.  The P669A mutation retains the C
β
 
methylene feature but replaces the rest of the sidechain with H.  The trans isomer in 
this sequence (-VpTAEE-) should be stabilized to ~ 100% and adopt the same 
structure as VpTPEE in pAICD.  Although binding of pAICD-P669A to trans-specific 
cellular partners might be weakened due to the increased conformational flexibility of 
the free peptide (Ala has more conformational degrees of freedom than Pro) or by sub-
optimal packing to hydrophobic pocket due to loss of Pro ring atoms.  The P669V 
mutation retains both the C
β
 and C
γ
 positions of Pro but adds a CH3 group close to the 
backbone.  The interaction of pAICD-P669V with trans-specific binding partners 
might be weakened due to the bias of Val towards extended conformations and 
possible steric clashing in binding interfaces.  Such weakened affinities can be 
overcome by the use of higher inhibitor concentration as long as these Pro-substituted 
peptides are specific for the trans isomers specific binding partners. 
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Identification of isomer-specific binding partners 
There are potentially several different binding partners, most likely proteins, in 
the cell that bind to the VpTPEE region of AICD. The relative populations of cis-
specific and trans-specific binding partners of the VpTPEE sequence in the cell is 
entirely unexplored and is therefore unknown.  Due to the distinct structural features 
of the cis and trans isomers, it is unlikely that a single binding partner would tightly 
bind to both forms.  Since we are anticipating a trafficking role for these binding 
partners, a tighter and highly specific interaction is expected.  Anticipating proteins as 
the major binding partners, we utilized Benzophenylalanine (Bpa) (Figure 4.3a) as a 
photo-activable group (Dorman and Prestwich, 1994) to covalently capture the binding 
partners and facilitate their identification.  The strategy of this “fishing experiment” is 
outlined in Figure 4.3b.  In these experiments, the probe consists of three components: 
1. The “bait‟ is cis analogue, trans analogue or natural sequence 
(VpTPEER) from pAICD. 
2. The “hook” is the Bpa which is photo-activated by UV irradiation at 
350-360nm and covalently binds to nearby C
α
-carbon of the binding 
protein. 
3. Biotin as a tag to identify or purify the covalently bound binding 
protein. 
The cell lysate is incubated with the probe allowing the equilibration of the isomer-
specific interactions and then irradiated with UV light to covalently trap the binding 
partners.  Cell lysate is then analyzed by Western blotting where horseradish 
peroxidase-linked streptavidin is used to identify the binding partners. 
In order to identify the isomer-specific binding partners, two strategies are 
being used.  First, the natural sequence (VpTPEER) is used as the bait and the cis 
(pCDP) or trans (trans-locked A or B) locked molecules are used as inhibitors.  In this 
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Figure 4.3:  a)  The chemical structure of the photoactivable group, benzophenyl 
alanine (Bpa).  This special amino acid can be easily put in any peptide sequence 
using standard peptide synthesis methods.  b)  Strategy of the fishing experiment.  Cell 
lysate is incubated with the peptide probe which results in binding of the cellular 
binding partners with the „bait‟ in the probe.  The lysate is then irradiated by UV light 
(340-350 nm) which results in covalent linkage between the probe and the binding 
partner.  The whole cell lysate is then run on a gel and probed with strepdavidin-horse 
radish paroxidase (HRP) to visualize and subsequently identify via mass spectrometry 
the binding partners.  c)  The probes and inhibitors (trans-locked and cis-locked) used 
in the fishing experiments.  Probe1 has the natural pAICD sequence which has 93% 
trans and 7% cis population.  This probe is used in conjunction with the trans or the 
cis locked inhibitors.  Probe2 has the cis-locked pCDP as the bait.  Probe3 has Val in 
place of Pro669 which would make it ~100%, i.e. it has the trans-locked peptide as the 
bait. 
 
 
 
 
 
 
 
 
 
81 
 
 
 
 
 
 
 
82 
 
case the cell lysate will be probed with and without the inhibitors and both would be 
run and compared on a gel.  It is important to note that the cell lysates can be prepared 
from various cell lines such as breast cancer cell line (HeLa cells), Chinese hamster 
ovary (CHO) cells or neuroglia cells (H4) each containing endogenous Pin1 or Pin1 
knocked-down.  The fact that VpTPEER has only 7% cis population should not 
hamper the identification process in the presence of trans-locked inhibitors.  The 
inhibitors would block the trans-specific binding partners which would result in the 
interaction of the probe with the cis-specific binding partners.  Binding of the cis 
isomer of the probe would deplete the free cis population, resulting in the 
isomerization of free trans to free cis.  The trans to cis isomerization rate (ktc) is 
0.00064 s
-1
 in the absence of Pin1.  To get ~99% conversion to cis, the probe, cell 
lysate and inhibitor should be incubated for at least 2hrs.  The second strategy is to use 
the pCDP or trans-locked peptides themselves as probes. 
The use of Bpa as the photo-activatable group in the probe of the fishing 
experiments provides the following advantages: 
1. Bpa is chemically more stable than other groups such as diazo esters, 
aryl azides and diazirines.  Moreover, Bpa is commercially available as 
a special aminoacid and can be easily attached to peptide probes using 
standard solid phase synthesis. 
2. It is activated by non-damaging wavelengths for proteins. 
3. It reacts preferentially to the unreactive Cα-H bond even in the presence 
of solvent water and other nucleophiles.  This avoids the diffusion or 
release of the activated Bpa that can result in solvent trapping or 
nonspecific labeling. 
4. The low lifetime (80 μs – 120 μs) of the Bpa excited state also reduces 
non-specific binding. 
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Figure 4.4:  Synthesis of cyclic dipeptide.  Fmoc and tBu protected threonine (1) was 
coupled to prolinamide (2) using DCC as a coupling reagent.  The Fmoc protection 
group was removed from the dipeptide (3) using 20% piperidine and then cyclized 
using TEA as base to produce the protected cyclic dipeptide (5) as the final product. 
 
Materials and Methods 
Synthesis of six amino acid cyclic peptide 
A six residue phosphopeptide corresponding to pAICD residues V667 to R672 
was synthesized commercially (Tufts Core Facility) by solid phase synthesis and 
obtained on the resin.  As part of the peptide design, the E670 side chain COOH was 
protected by orthogonal protection O-trimethylsilylethyl group (-OTMSEt) while all 
other functional groups in the peptide were protected by acid labile protection groups.  
The E670 sidechain was specifically deprotected by 1M TBAF prior to cyclization.  
The amide bond between E670 sidechain and V667 NH2 was formed using 1e.q. 
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dicyclohexylcarbodiimide (DCC) (Sheehan and Hess, 1955) and 0.1 e.q. 1-hydroxy-
benzotriazole (HOBT) in dimethylformamide (DMF) as solvent.  The reaction was 
monitored using ninhydrin test which detects free N-terminus.  Finally, the peptide 
was cleaved from the resin and all the protecting groups removed using trifluoroacetic 
acid (TFA).  The peptide was purified by solvent extraction using water and diethyl 
ether and then analyzed by NMR and mass spectrometry. 
 
Synthesis of phosphorylated cyclic dipeptide (pCDP) 
The route for synthesis (Faden et al., 2003) of cyclic pThr-Pro dipeptide 
(pCDP) is shown in Figure 4.4.  The solvent DMF was dehydrated overnight on silica 
beads.  One eq. of Fmoc and tBu protected threonine (1) was dissolved in 
dimethylformamide (DMF) at 0°C (ice bath).  Another 1 eq. of prolinamide (2) and 
1eq. of DCC was added to it and stirred for 10 mins at 0°C.  HOBt (1 eq) solution in 
DMF was added and the reaction mixture was stirred overnight at room temperature.  
The insoluble precipitate was filtered out. The filtrate has the product (3).  The solvent 
DMF was removed using high vacuum and then the product (3) was dissolved in 20% 
piperidine in DMF to remove the Fmoc protection group from threonine amine.  The 
reaction mixture was stirred at room temperature for 45 min.  The solvent was again 
removed and the deprotected product (5) was dissolved in 5ml of dichloromethane 
(DCM) and 5ml of triethyl amine (TEA).  This reaction mixture was stirred at room 
temperature overnight.  Next day, the reaction mixture was diluted with DCM and 
washed with saturated NaHCO3 solution (2 20 mL) followed by brine (20 mL). The 
organic layer was dried using anhydrous Na2SO4, concentrated under reduced pressure 
and purified on a silica gel column.  Compound (5) is the protected cyclic dipeptide. 
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Figure 4.5:  Phosphorylation of cyclic dipeptide.  The tBu protection group was 
removed from the protected cyclic dipeptide (5) using 25% TFA.  The reagent 
isopropyl phosphoramidite was used to put O-benzyl protected phosphite on the 
threonine sidechain.  The phosphite (7) was oxidized to phosphate (8) using t-butyl 
hydroperoxide.  The O-benzyl protection groups were removed to get the final 
product, phosphorylated cyclic dipeptide (9). 
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Phosphorylation of the cyclic dipeptide (Zhao and Etzkorn, 2007) was carried 
outas shown in Figure 4.5.  The tBu protection group on theronine sidechain was 
removed by 25% TFA in DCM.  The deprotected compound (6) was dissolved in 40ml 
acetonitrile and 4 eq. of tetrazole, and 2 eq. of (iPrO)2PN-iPr2 was added to it.  The 
reaction mixture was stirred at room temperature for 20h.  The reaction mixture was 
cooled at -40°C for 10 min and tert-Butylhydroperoxide (5.5 M in decane, 2 eq.) was 
added to it dropwise.  The mixture was stirred at -40°C for 40 min.  The cold bath was 
removed and the reaction mixture was stirred for an additional 45 min.  It was again 
cooled back to 0°C and 10% aq. Na2S2O3 (40 mL) was added to quench the reaction.  
It was stirred for 10 min and transfered to a separatory funnel using Et2O (3×30 mL).  
The combined organic layer was washed with 10% aq. Na2S2O3 (2×20 ml) and brine 
(20 mL), dried with Na2SO4 and concentrated to get (8).  The protected 
phosphorylated cyclic dipeptide (8) was dissolved in 10mL of TFA:TIS:H2O 
(95:2.5:2.5) and stirred for 2.5h.  The TFA was evaporated by blowing dry nitrogen 
gas.  It was then put under high vacuum to remove residual TFA and obtain the final 
product (9). 
Figure 4.6:  Proposed synthetic route for attaching bisPOM protected phosphate on 
cyclic dipeptide. 
 
Attaching the bisPOM protection group 
The protection of the phosphate group on pCDP by bis-pivaloyloxymethyl 
(bisPOM) can be accomplished according to the route shown in Figure 4.6.  The  
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Figure 4.7:  Two alternative routes for attaching a linker group to the phosphorylated 
cyclic dipeptide. 
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deprotected unphosphorylated cyclic dipeptide (6) is reacted with chloro-phosphoryl 
bisPOM reagent in the presence of triethylamine (Et3N) in diethyl ether (Et2O) 
(Hwang and Cole, 2004) to give the bisPOM protected cyclic dipeptide (10). 
 
Proposed synthetic route for attaching linker on pCDP 
Two alternative synthetic routes are proposed for the attachment of the linker 
(Estiarte et al., 2001) on pCDP (Figure 4.7).  The already synthesized protected 
phosphorylated cyclic dipeptide (8) can be alkylated with benzyl bromoacetate (15) 
using lithium bis-trimethylsilyl amide (LHMDS) as base to get the product (17).  Even 
though this is a one step synthesis, the chances of its success are limited.  The strong 
base might degrade the compound (8) by reacting with the relatively labile O-benzyl 
protection group on phosphate.  Hence, this is proposed as an alternative route.  A 
better synthetic route would require a different starting material to synthesize the 
cyclic dipeptide as shown in Figure 4.7.  The amine of threonine is protected by t-
butyl carbamate (Boc) and the sidechain is protected by O-benzyl group.  The 
resulting cyclic dipeptide (14) will have O-benzyl protection on the theronine 
sidechain which can be selectively removed by hydrogenolysis later.  The linker group 
is added by alkylating with benzyl bromoacetate (15) using lithium bis-trimethylsilyl 
amide (LHMDS) as base to get the product (16).  Selective deprotection of O-benzyl 
protection group from the threonine sidechain of (16) and subsequent phosphorylation 
using the method described earlier would give the final product (17). 
 
NMR titration experiments 
The six amino acid cyclic peptide was titrated into 
15
N labeled WW domain 
(WWold construct).  Solution of the cyclic peptide was prepared by dissolving 2.5mg 
of purified peptide in 310μl of NMR buffer which results in 10.2mM peptide,  
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Figure 4.8:  a)  LC-EMS of the reaction mixture of the synthesis of the cyclic 
VpTPEER peptide.  Single-stage electrospray mass spectrometry spectrum shows 
peak at theoretical MW of cyclic peptide (791.8 amu) along with multiple impurities 
from reaction mixture.  b) Selective detection of phosphate-containing species, 
showing cyclic peptide as by far the dominant component (linear form at 809 is less 
than 3%).  c)  
1
H-
1
H TOCSY spectra of cyclic VpTPEER (left) and linear pAICD 
(right) phosphopeptides.  d)  The 
31
P spectra of cyclic VpTPEER (left) and linear 
pAICD (right) phosphopeptides.  The TOCSY and 
31
P spectra show the enhancement 
of cis content in the cyclic peptide. 
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assuming 100% purity.  The 
15
N WW domain was 0.43mM in NMR buffer consisting 
of 10mM HEPES, 10mM NaCl, 50mM Na2SO4, 1mM DTT and pH of 6.8.  
15
N-
1
H 
HSQC spectrum was collected for the apo protein.  For each titration point, 
concentrated cyclic peptide was added to the same sample, thus, progressively 
increasing the concentration of the peptide.  A total of 14 titration points were 
collected by adding 5, 5, 5, 5, 10, 10, 10, 10, 10, 80, 50, 15 and 30μl of cyclic peptide 
to the WW domain sample.  
15
N 
1
H HSQC spectrum was collected for each titration 
point.  For each HSQC experiment 2048×256 complex data points and 32 scans were 
acquired.  The spectra were processed using NMRpipe (Delaglio et al., 1995) and 
visualized with Sparky (Goddard, 2008).  The shifted-sinebell window function was 
applied to all data while processing and then zero filled. 
A similar titration experiment was also performed for cyclic the dipeptide 
(CDP) and the isolated PPIase domain of Pin1.  The concentration of 
15
N PPIase 
domain was 0.35mM.  
15
N-
1
H HSQC spectra were collected for four titration points 
with peptide (CDP) to protein ratio of 0, 0.5, 1, and 10. 
 
For each HSQC experiment 
2048×256 complex data points and 48 scans were collected. 
In order to titrate phosphorylated cyclic dipeptide (pCDP) into Pin1, a 
concentrated solution of pCDP was made by dissolving 11.4 mg of pCDP in 270μl 
H2O and 30 μl D2O with a final concentration of 137mM.  This peptide was 
progressively titrated into 
15
N labeled Pin1.  The NMR buffer was 10mM HEPES, 
10mM NaCl, 1mM DTT, 5mM NaN3 and pH of 7.0.  A total of six titration points 
were collected.  The protein concentration was 0.35mM and the ratio of the peptide to 
protein used was 0, 1, 10, 30, 50 and 77.  
15
N-
1
H HSQC spectrum was collected for 
each titration point.  For each HSQC experiment 2048×128 complex data points and 
48 scans were collected. 
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Results and Discussion 
Cyclic peptide increases the cis content of VpTPEER sequence 
This six residue peptide (V-pT-P-E-E-R) was commercially synthesized as a 
linear peptide and was cyclized by forming an amide bond between the N-terminus 
NH2 on V667 and sidechain COOH of E670.  The extent of cyclization was quantified 
(Figure 4.8 a and b) by on-line LC/MS/MS using a triple quadrupole linear ion trap 
(4000Q Trap) performed in Cornell‟s BioResource Center.  The cyclization was ca. 
~100% complete.  Since the reaction mixture contains almost 100% cyclic peptide, we 
analyzed the reaction mixture by NMR to determine cis and trans populations.  2D 
1
H-
1
H TOCSY (Figure 4.8c) and 1D 
31
P (Figure 4.8d) spectra of the reaction mixture 
detect 30% cis content of the cyclic peptide which is considerable improvement on the 
7% cis content of the linear peptide.  The 2D 
1
H-
1
H TOCSY spectrum (Figure 4.8c) 
shows two cis populations that most likely reflect different hydrogen bond geometries 
adopted in the cis isomer. 
 
Interaction of cyclic peptide with 
15
N-labeled isolated WW domain 
Titration of the cyclic peptide into isolated 
15
N labeled WW domain showed 
chemical shift changes distinct from the titration of the linear peptide into isolated 
15
N 
labeled WW domain (Figure 4.9 a and b).  The chemical shift changes are due to the 
interaction of the trans conformation of the cyclic peptide which has a population of 
~70%.  Moreover, the differences in the trajectories of the peak shifts of the WW 
domain residues in response to linear and cyclic peptide titration indicate the different 
structures of the two trans peptides.  No further experiments were performed with this 
cyclic peptide but it might be interesting to study the interaction of this cyclic peptide 
with cis specific binding partners, once they are identified. 
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Figure 4.9:  a)  Titration of cyclic peptide VpTPEER into 
15
N labeled isolated WW 
domain.  
15
N-
1
H HSQC spectra acquired at each titration point are overlayed.  b)  
Titration of the linear peptide TAR1 into 
15
N labeled isolated WW domain.  
15
N-
1
H 
HSQC spectra acquired at each titration points are overlayed.  Comparison of the two 
overlays (a and b) show less peak shifts in case of the cyclic peptide (a) and also 
different trajectories for some WW domain residues. 
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Successful synthesis of pCDP 
The phosphorylated cyclic dipeptide was successfully synthesized using the proposed 
scheme (Figures 4.5 and 4.6).  1D (
1
H) and 2D (
1
H-
1
H COSY, 
13
C-
1
H HMQC and 
13
C-
1
H HMBC) experiments were used to verify the structure of the compound.  The 
completely assigned 1D-spectrum of pCDP is shown in Figure 4.10a.  The H
α
 (Figure 
4.10b) of the threonine residue showed two-bond and three-bond coupling to the two 
carbonyl carbons, thus, validating the cyclic product.  Further, ESI mass spectrum 
(Figure 4.10c) was obtained for the final product, and confirmed the correct mass for 
the pCDP compound (276.8 Da).  Finally the doublet peak for threonine methyl was 
used to determine the purity of the product (Figure 4.10d).  The final product was 
found to be greater than 95% pure. 
 
Interaction of unphosphorylated CDP with PPIase domain 
The WW domain of Pin1 binds specifically to the trans isomer of pSer/Thr-Pro 
motif whereas the PPIase domain seems to have higher affinity for cis than trans 
isomer.  The first crystal structure (pdb code: 1PIN) solved for Pin1 had Ala-Pro 
dipeptide in the cis conformation bound to the PPIase domain (Ranganathan et al., 
1997).  Since the cyclic dipeptide is locked in the cis conformation, it should not be 
catalyzed by PPIase domain of Pin1 and should simply bind it.  Moreover, we do not 
expect CDP to bind the PPIase domain tightly as CDP is a substrate analogue and not 
a transition state analogue.  This provided us with an ideal opportunity to test the 
necessity of the  phosphate group on substrates being recognized by this domain.  We 
titrated in the unphosphorylated CDP into 
15
N labeled PPIase domain.  No peak shifts 
were observed even at 10:1 ratio of peptide to protein (Figure 4.11).  Thus, the 
presence of phosphate group on the substrates is absolutely necessary for recognition 
by the PPIase domain of Pin1. 
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Figure 4.10:  a)  
1
H spectra of purified phosphorylated cyclic dipeptide (pCDP) in D2O 
at 600MHz shows pure compound.  Inset shows the structure of pCDP and the peaks 
in the spectrum are assigned as indicated.  b)  A section of the 
13
C 
1
H HMBC spectrum 
showing the two and three bond couplings of the α-protons to the carbonyl carbons.  c)  
ESI-MS of pCDP confirms the purity of the sample and the success of the synthesis.  
The negative mode ESI mass spectrum was obtained for pCDP.  d)  The strong methyl 
doublet peak of the threonine sidechain was used to determine the purity of the 
sample.  Peak integration shows the major product as more than 95%. 
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Figure 4.11:  Titration of unphosphorylated cyclic dipeptide into 
15
N labeled isolated 
PPIase domain of Pin1.  No significant binding is observed. 
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Figure 4.12:  Titration of phosphorylated cyclic dipeptide into 
15
N labeled isolated 
Pin1.  Significant peak shifts are observed only in the PPIase domain. 
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Interaction of pCDP with Pin1 
The phosphorylated cyclic dipeptide (pCDP) was titrated into 
15
N labeled Pin1 
in order to determine its specificity for the two domains of Pin1, PPIase and WW 
domain, and also the corresponding binding affinities.  The titration experiment 
revealed that pCDP interacts specifically with the PPIase domain of Pin1.  Chemical 
shift changes were not detected for the WW domain residues in this titration 
experiment, whereas the active-site residues of PPIase displayed considerable 
chemical shift changes (Figure 4.12).  Residues in the PPIase domain that show 
considerable chemical shifts are R69, S114, S115, S154 and G155.  The absence of 
interaction between pCDP and WW domain, and its binding to the active-site of 
PPIase domain (Figure 4.13) confirms our prediction that it mimics the cis isomer of 
pThr-Pro motif in pAICD.  The chemical shift changes of the PPIase domain active-
site residues from the titration experiment were used to determine the binding affinity 
of pCDP to the PPIase domain of Pin1.  The residues R69, S114, S115, S154 and 
G155 displayed the largest chemical shift changes and were fit simultaneously (Figure 
4.14) to determine the dissociation constant (KD).  The dissociation constant of pCDP 
to PPIase domain of Pin1 was determined to be 3mM.  Since this small molecule 
mimics one of the substrates (cis isomer) of the enzyme Pin1, the weaker binding 
affinity is expected.  Enzymes perform their catalytic activities by binding the 
transition-state tightly, thus, lowering the activation energy barrier and bind the 
substrates and products weakly for their efficient release.  Thus, the small molecule 
pCDP is a true substrate analogue of Pin1 and mimics the cis isomer of pThr-Pro 
motif.  This supports our prediction that pCDP and compound library based on this 
lead molecule should not inhibit Pin1.  Importantly, these molecule are expected to 
bind tightly and competitively inhibit the cis-isomer specific binding partners in the 
cell. 
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Figure 4.13:  Interaction of pCDP with the active-site residues of the PPIase domain of 
Pin1.  A molecular model of pCDP is docked into the active-site of the PPIase domain.  
The active-site residues are labeled and the H-bond interactions are shown as broken 
lines 
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Figure 4.14:  Fitting of the chemical shift changes due to titration with pCDP for the 
active-site residues of PPIase domain in Pin1 to determine the dissociation constant, 
KD.  The green lines are the fitted curve. 
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Effect of pCDP cyclic dipeptide on APP processing in neuroglioma cells. 
The effect of pCDP on APP processing was studied in the lab of collaborator 
Dr. Kun Ping Lu (BIDMC, Harvard Medical School) by measuring the secreted 
products of APP processing, in a pCDP dose-dependent manner, in cultures of human 
neuroglioma H4 cells and stable Pin1 knockdown H4 cells.  The assay is based on the 
quantification of αAPPs, the product of non-amyloidogenic processing of APP.  
Preliminary experiments performed by Suk Ling Ma in the Lu lab indicate that levels 
of αAPPs increase in human neuroglioma H4 cells after treatment with pCDP (Figure 
4.15). This dose-dependent effect of pCDP was even more profound in stable Pin1 
knockdown H4 cells, which is consistent with our previous results showing that more 
APP is processed by amyloidogenic pathway in Pin1 knockdown or knockout cells, as 
compared with Pin1 wild-type cells (Pastorino et al., 2006). These results indicate a 
shift toward the non-amyloidogenic processing pathway in a dose-dependent manner 
in response to treatment with the cis mimetic small molecule pCDP.  Also, this result 
provides preliminary evidence justifying our hypothesis that the cis isomer of pAICD 
might favor the amyloidogenic processing of APP.  
However, the high concentrations (>100 μM) required for efficacy signify that 
considerable improvement is required in order to acquire drug-level potency.  The low 
potency observed for the pCDP could be either due to poor cellular uptake of the 
compound or to low binding affinity with its putative cellular target.  The poor cellular 
uptake of pCDP is expected based on the anionic phosphate group.  The fact that 
pCDP enhances the non-amyloidogenic processing despite its poor cellular uptake is 
very encouraging and provides impetus for the development of cis analogues based on 
this molecule.  The proposed library of compounds should provide necessary 
improvement of the binding affinity to the cellular target(s).  Moreover, identification 
of the actual targets would tremendously help in the rational design of inhibitors. 
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Figure 4.15:  Phospho-Thr-Pro cyclic dipeptide promotes non-amyloidogenic APP 
processing in wild-type as well as stable Pin1 knockdown human neuroglioma H4 
cells in a dose-dependent manner.  Increase in αAPPs is observed for both H4-control 
cells expressing endogenous Pin1 and H4-Pin1-siRNA cells stably expressing the 
siRNA sequence for Pin1. Briefly, cells were grown in 6 well dishes, and each 
treatment was done in triplicate. Conditioned media were collected in presence of 
protease inhibitors, and centrifuged at 1400rpm for 10 min at 4C to pellet cell debris 
and avoid cross contamination with full length APP. Supernatants were transferred to 
a fresh tube and αAPPs was immunoprecipiated using 6E10 antibody (Covance). After 
elution from the beads, samples were run onto 6%SDS-PAGE, and blotted onto 
PVDF. Detection of both αAPPs and total APP was performed using the monoclonal 
antibody 22C11 by means of western blot (Chemicon).  Total cell lysates were used to 
probe for total APP and Pin1 expression.  These experiments were performed by Suk 
Ling Ma in Dr. Kun Ping Lu‟s laboratory in Harvard Medical School, Boston, MA.  
This figure was supplied by Suk Ling Ma. 
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Figure 4.16:  Western blot of the whole cell lysate visualized by enhanced 
chemiluminiscence.  The protein bands that are different between lanes 2 and three are 
indicated by arrows.  The two most prominent bands between 25 to 30 KDa are 
enclosed in a box.  These „fishing‟ experiments were performed by Ross Resnick, 
research support specialist, of the Nicholosn lab.  This figure was supplied by Ross 
Resnick. 
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Identification of isomer-specific binding partners 
In order to identify cis-specific binding partners, “fishing” experiments 
utilizing the above described probes and inhibitors are being pursued by Ross Resnick, 
research support specialist, in the Nicholson lab.  As an example, pCDP was used as 
inhibitor, and a probe containing the natural sequence VpTPEER was used as the 
„bait‟.  Whole cell lysates (WCL) were prepared from Pin1-/- mouse breast cancer cells 
and were preincubated with pCDP.  The probe was added to the lysate, incubated and 
then irradiated by UV light.  Proteins were resolved on 8-20% reducing/denaturing 
SDS-PAGE gel transferred to PVDF membrane and then probed with streptavidin-
HRP (horseradish peroxidase) and the results were visualized by enhanced 
chemiluminescence (Figure 4.16).  Lane 1 is a negative control where probe was not 
added to the whole cell lysate.  The two bands visible in this lane are due to non-
specific binding of streptavidin or HRP to proteins in these two bands.  For all other 
bands in the next two lanes, a covalent linkage of the proteins to the peptide through 
Bpa is necessary for visualization.  Lane 2 is without pCDP as the inhibitor.  The 
different bands consist of proteins which recognize cis isomer, trans isomer or other 
region of the probe.  Lane 3 is with pCDP as an inhibitor.  Certain bands in these lanes 
can be seen missing when compared to lane 2 (noted by arrows).  These bands most 
probably correspond to proteins that bind to pCDP.  The next steps are the 
identification of the proteins in these bands and the validation of their binding and 
isomer-specificity to pAICD by NMR 
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CHAPTER 5 
MODELLING THE PH-FOLDING SWITCH IN THE PSEUDOMONAS 
SYRINGAE EFFECTOR PROTEIN AVRPTO USING YANG-HONIG MODEL 
 
Introduction 
The Type Three Secretion System (T3SS) is a needle shaped nano-device used 
by gram-negative bacteria to infect host plant cells (Figure 5.1a).  The pathogenic 
bacteria utilize the T3SS to inject effector proteins into the host cells (Galan and 
Collmer, 1999).  These effector proteins suppress the basal and hypersensitive 
response (HR) defenses of plant cells, thus, enabling the pathogen to grow in the plant 
apoplast.  The basal defense involves the formation of callose rich papilla below the 
cell wall, synthesis of reactive oxygen species (peroxide H2O2 and superoxide O2
-
) 
(Dangl and Jones, 2001) and upregulation of defense associated genes.  The HR is 
much more specific and complicated.  It is triggered by certain phytopathogen 
effectors resulting in localized cell death and increased defense of surrounding plant 
tissues.  Hence, the efficient transport of the effector proteins through the T3SS into 
the host cell, in order to suppress these defense mechanisms, is one of the key steps for 
the virulent activity of the pathogens. 
The T3SS is evolutionarily related to bacterial flagellum (Saier, 2004). It is 
composed of ring structures associated with the inner and outer membranes of the 
bacteria and a needle like structure called pilus reaching into the plant cell (Figure 
5.1a) (Cornelis, 2006).  A dodecameric ATPase is attached to the base of the ring 
structure and is postulated to take part in unfolding and translocation of the effector  
_______________________ 
This chapter is based on manuscript published courtesy of Proceeding of the National 
Academy of Sciences of the United States of America (Dawson et al., 2009). 
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Figure 5.1:  a)  The T3SS of pathogenic bacteria spans the inner and outer membranes 
of the bacteria and the host cell wall.  The effector proteins are in the mildly acidic 
bacterial cytoplasm which assists in their unfolding and translocation through the 
narrow pilus of the T3SS into the host cytoplasm.  The host cytoplasm is at neutral pH 
which assists in the refolding of the effector proteins and subsequent signaling 
mechanisms leading to triggering or suppression of the hypersensitive response (HR).  
b)  The TrAvrPto structure with the seven histidine residues and the lone tryptophan 
residue dispersed across it.  This figure is reproduced with permission from Dawson 
et. al., 2009. 
 
proteins (Galan and Wolf-Watz, 2006).  The inner diameter of the pilus typically 
ranges from 2 to 3 nm (Cornelis, 2006).  This presents a unique problem for the 
translocation of the effector proteins through the T3SS.  Most of the effector proteins 
have a minimum structural dimension greater than 2 nm which makes it difficult to 
explain how the folded proteins get through the narrow pilus.  In order to explain this 
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discrepancy it was hypothesized that the proteins have to partially unfold before 
getting into the T3SS (Feldman et al., 2002).  The elegant work of Lee (Lee and 
Schneewind, 2002) and Feldman (Feldman et al., 2002) provided initial supporting 
evidence for this hypothesis.  Feldman and co-workers showed that the N-terminal 
secretion signal (residues 1-16) of the effector protein YopE is unable to result in the 
secretion of the stable wild type dihydrofolate reductase (WT DHFR) while the same 
signal can affect the secretion of a destabilized mutant of DHFR.  Lee and Schneewind 
showed similar results for ubiquitin.  Furthermore, Feldman and co-workers proposed 
that the chaperones associated with T3SS are responsible for keeping their substrate in 
a partially folded state in order to facilitate secretion.  Birtalan et. al. (Birtalan et al., 
2002) found that the chaperones act locally by binding to the chaperone binding 
domain of the effector proteins and do not contribute to the global unfolding of the 
proteins.  Also, not all effector proteins have an associated chaperone and therefore, 
are translocated in a chaperone independent manner (Buttner and Bonas, 2006).  This 
necessitates the postulation of an alternative hypothesis that would explain the ability 
of effector proteins to unfold unassisted, translocate through the T3SS and refold once 
in the host cytoplasm. 
Pseudomonas syringae pv. tomato is one of the most well-studied plant 
pathogens which causes bacterial speck disease in tomato (Mudgett, 2005).  One of its 
effector proteins, AvrPto, has been studied as a model system for chaperone 
independent translocation through the T3SS (Alfano and Collmer, 2004).  AvrPto acts 
as a virulence factor in non-resistant plants and thus, promotes the bacterial growth.  
In resistant plants it binds to the host Pto kinase and triggers its defense system 
(Scofield et al., 1996).  The NMR structure of a truncated version of AvrPto 
(TrAvrPto) has been solved (PDB ID 1R5E) (Wulf et al., 2004), which reveals a three-
helix bundle and a long Ω-loop (Figure 5.1b).  TrAvrPto has been shown to retain 
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similar Pto-binding as AvrPto and TrAvrPto also elicits Pto-mediated immunity in 
resistant plants (Wulf et al., 2004).  Detailed kinetic and thermodynamic studies on 
TrAvrPto revealed the inherent instability of the protein (Dawson and Nicholson, 
2008).  At pH = 6.1 the protein has 16% unfolded population and undergoes slow 
exchange between the folded and unfolded states.  Studies at pH 6.1 and 7.0 showed 
that the TrAvrPto stability is highly dependent on pH.  Thus, the folded core of 
TrAvrPto possesses a pH-regulated folding switch which can be utilized by the plant 
pathogens to translocate the effector protein. 
It is essential for bacteria to adapt rapidly to their environment in order to 
grow.  Plant pathogens such as P. syringae invade the host cell from the plant apoplast 
which is mildly acidic (pH 5.0 to 6.5 (Grignon and Sentenac, 1991)).  There the 
bacteria assemble the T3SS which connects its interior to the host cell cytoplasm.  The 
cytoplasmic pH of the bacteria has to be 0.5 – 1.0 pH unit higher than the apoplast as 
the T3SS requires a positive proton gradient (Minamino et al., 2003; Wilharm et al., 
2004).  The plant cell cytoplasm typically has a neutral pH (~7.4).  Thus, a pH-
gradient is present on the two extremes of the T3SS from mildly acidic (bacterium) to 
neutral (host cell), and nature has elegantly utilized this to translocate effector proteins 
by tuning their folding in this pH range (Figure 5.1a). 
 
Materials and Methods 
The circular dichroism (CD) and Trp fluorescence (Fl) thermal denaturation 
experiments were performed (Dawson et al., 2009) at different pH values to get the 
pH-dependence of the global folded population (pF) of the WT TrAvrPto.  The pH-
dependence of pF for the wild type protein was also obtained from the 
15
N-
1
H HSQC 
experiments at 26.6 °C.  Since the pH-dependence of pF obtained from the three 
different experiments report on the same physical phenomenon, the combined data 
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was fitted simultaneously to the two-state multi-titration model based on the Yang and 
Honig model (Yang and Honig, 1993).  For the mutant H87Y, Fl data was collected at 
25 °C to get the corresponding pH-dependence and was fitted to the same model 
(Dawson et al., 2009). 
 
Figure 5.2:  The multi-titration two-state Yang and Honig model.  The denaturation 
free energy GF→U is separated into pH-dependent (Gion =    
    -    
   ) and pH-
independent (Gneutral) components.  The populations of the F and U states are related 
to the pKa of individual ionizable residues (i) in each state j via    
   .  This figure is 
reproduced with permission from Dawson et. al., 2009. 
The Yang and Honig model expresses pF as a function of pH with the pKa‟s of 
various ionizable groups in the unfolded (U) and folded (F) state of the protein and ƒ, 
the ratio of neutral U and F, as model-parameters. This is achieved by separating the 
denaturation free energy (GF→U = Gneutral + Gion) into pH-dependent (Gion) and 
pH-independent (Gneutral = -RTln(ƒ)) components, where Gneutral is the denaturation 
free energy of the protein when all its ionizable groups are in the neutral state, and 
Gion =    
    -    
   , where    
    (j = U or F) is the difference in free energy 
between the ionized and neutral forms of state j. Neglecting interactions between 
charged groups in each state,    
    is given by (Yang and Honig, 1993): 
   
                      γ
 
         
 
          (5.1) 
where N is the number of ionizable groups, i is -1 or +1 for an acidic or basic group, 
respectively, and      
 
 is the pKa of the i
th
 ionizable group in state j. Since    
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depends only on the      
 
values and pH, the above model expresses the pH-
dependence of GF→U (and hence, of pF) for a given set of      
 
values (Figure 5.2).  It 
is worth mentioning that Gion depends on differences between pKa values in the U 
and F states. Titrating groups with elevated or depressed    
  relative to    
  will 
dominate the pH-dependence of stability.  
In order to determine the protein stability at each pH, populations were  
calculated from ƒ (ƒ = 
  
       
  
        ),    
    and    
    (Figure 5.2). The total  
folded population as observed by the various physical techniques was calculated as 
  
    =   
        +   
   , the sum of neutral and ionized folded populations. The       
  
for all the seven histidine sidechains were determined by NMR titration experiments. 
Hence, these values were not used as fitted parameters.  For the unfolded protein 
      
     , typical for solvent exposed histidine sidechains (Nozaki and Tanford, 
1967), was used for all histidines.  Thus, the only fitted parameters were         
 , 
        
  and ƒ. The H87Y pF vs. pH experimental data was fitted by omitting the 
contribution of H87 from the calculation of Gion, but otherwise using the same pKa 
values as for the wild type best-fit and varying ƒto optimize the fit. 
 
Implementation of data-fitting by non-linear least-squares regression 
Regression analysis is one of the most common methods of analyzing 
numerical data consisting of a set of dependent (Y
obs
) and independent variables (X). 
In order to analyze the data, a model needs to be devised such that the dependent 
variable is defined as a function of the independent variables, equation (5.2). The 
function also consists of a set of parameters (a) and an error term (). The error term 
accounts for the deviation of the dependent variables from the model. The defined 
function, also called the regression equation, can be linear or non-linear in terms of the 
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model parameters. Hence, for a given dataset (Y
obs
, X), a regression equation can be 
defined as follows: 
Y
calc
 = f(X, a) +         (5.2) 
where Y
calc
, X, a and  are the set of calculated dependent variables, independent 
variables, model parameters and errors respectively. Once the model is defined, the 
next step is to calculate the Weighted Sum of Squared Errors (WSSE) given by: 
            
         (5.3) 
where  is the set of experimental errors associated to the dataset (Yobs, X).  The errors 
 are normally determined from repeated measurements or by propagation of errors.  
From equation (5.3), it can be seen that datapoints (Y
obs
, X) with larger error () 
would contribute less to the WSSE that those with smaller errors. Hence, the 
datapoints with smaller errors would influence the fitting more than those with the 
larger errors.  In the absence of experimental errors, a constant error () is used, thus, 
giving equal weight to all the datapoints.  
The best-fit parameters of the model (equation (5.2)) can be determined by 
minimizing the WSSE. This is easily done by using standard equations (Press, 1988) 
in the case of linear models. Non-linear models require an iterative approach involving 
the following steps: 
1. An initial value needs to be guessed for the set of parameters and is given by 
a0. 
2. Using a0 and X, the set of dependent variables (Y
calc
) are calculated from the 
model such that Y
calc
 = f(X, a0). 
3. The WSSE is determined, where        
             
   
 
. 
4. Again a new set of parameters a1 is guessed and WSSE calculated. The new 
parameter set a1 is accepted if WSSEnew < WSSEold. There are several 
algorithms for adjusting the parameters, e.g. Gauss-Newton method, method of 
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steepest decent and Levenberg-Marquardt method. The Levenberg-Marquadt 
(Marquardt, 1963) method implements the best of the other two methods and is 
the one mostly used. 
5. Step 4 is repeated until the change in WSSE is less than a tolerance value or a 
maximum number of iterations are reached. The parameter set (abestfit) for the 
best-fit result is reported along with the corresponding WSSE. 
6. The precise value of abestfit depends partially on the initial guess a0, and hence, 
the iterations should be performed with at least three different initial guesses in 
order to prevent fitting artifacts. 
 
Figure 5.3:  A flow chart depicting the implementation of the data fitting program in 
MATLAB.  The start box indicates the program run by the user.  All other boxes 
except Result.txt are MATLAB mechanism files and Result.txt is the final output file 
containing the results of the data fitting. 
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Determination of the best-fit parameters is only the first part of data-fitting to a 
model. It is also necessary to estimate the confidence limits of the parameters being 
fitted by regression. Again, for linear regression standard equations are available for 
the determination of the confidence limits (Press, 1988). For non-linear regression, the 
confidence limits can be estimated by Monte Carlo Simulation. This is a rigorous and 
computationally intensive method. Fitting the experimental dataset to the theoretical 
model gives us the best-fit parameters abestfit for that dataset. Varying the experimental 
dataset by adding random error to each point and fitting it to the same model would 
generate another set of fitted parameters ai. Thus, the variance of the fitted parameters 
a can be determined by generating a set of synthetic dataset and calculating the 
distribution of ai. Here it is assumed that the distribution of ai about abestfit is the same 
as that about aactual, which is the set of actual values for the parameters a (Press, 1988). 
The nonlinear least-squares regression routine to fit the Yang and Honig model 
(Yang and Honig, 1993) to the experimental data was implemented in MATLAB
®
 
2007a. The routine DatafitError.m (Figure 5.3) implements the code for fitting of the 
experimental data by non-linear regression. The data fitting is started by running 
DatafitError.m, which passes the initial guess for the fitting parameters (        
 , 
        
  and ƒ) along with the fitting model to the MATLAB function lsqnonlin. The 
fitting model is defined in the routine model.m, which accepts the fitting parameters, 
calculates the folded populations (  
    ) and returns an array containing the weighted  
error ( 
   
    
    
     
   ) at each pH. The function lsqnonlin minimizes the WSSE 
(  
   
    
    
     
   
 
) by iteratively changing the fitting parameters and returns  
the best-fit parameters. The Levenberg-Marquadt algorithm (Marquardt, 1963) is used 
to search for the best-fit parameters. The minimization routine can be optimized by 
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changing some of the options of lsqnonlin, e.g. maximum iterations and maximum 
function evaluations. 
In order to estimate the confidence limits, the best-fit parameters are passed into 
the routine ShakeSimDataErrorEstimateMC.m, which in turn utilizes the routine 
model_pFcalc.m to calculate the populations (  
    ) using the best-fit parameters and  
the fitting model. This routine calculates the standard deviation (σ        
 
 
   
    
    
    
     
 
) of the best-fit curve (  
     vs. pH) from the experimental  
dataset (  
    vs. pH) which is then used to generate simulated datasets with normally 
distributed random noise about the best-fit curve.  Each simulated dataset i is fit to the 
same model as done previously for the experimental dataset yielding best-fit 
parameters ai. The standard deviation of the best-fit parameters ai over all of the 
simulated datasets is determined and reported as the confidence limit for the fitted 
parameters bestfit. For a good estimate of the confidence limit, a minimum of 100 
simulated datasets were used. 
Table 5.1:  The sidechain    
  for histidine residues as determined by 
15
N-
1
H HMQC 
experiments (Dawson et al., 2009) 
 
Residues H41 H54 H75 H87 H103 H125 H130 
   
  
6.32  
± 0.04 
5.88  
± 0.01 
6.89  
± 0.01 
4.8 ± 
0.1 
6.28  
± 0.02 
6.65  
± 0.01 
6.28  
± 0.03 
 
Results 
In order to elucidate the molecular mechanism employed by nature to tune the 
stability of TrAvrPto in the correct pH range, its acid denaturation was extensively 
studied by NMR, circular dichroism (CD) and Trp fluorescence (Fl) spectroscopies 
(Dawson et al., 2009).  Since AvrPto experiences a pH range of ~ 6 to 7.5 across the 
T3SS, it is necessary to identify residues that titrate in this pH range.  The sidechain of  
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Figure 5.4:  Folded populations (pF) of WT TrAvrPto versus pH at 26.6 °C from NMR 
(♦), CD (○) and Fl (Δ) experiments. The solid line is the fitted curve to the Yang and 
Honig model considering the histidine sidechain titrations only. This model fails to 
predict the pF at pH values less than 5. 
 
free histidine residue has a pKa of ~6.4 (Nozaki and Tanford, 1967) and hence, is the 
ideal candidate to provide the necessary pH-regulated folding.  
15
N-
1
H HMQC 
experiments were performed (Dawson et al., 2009) to determine the pKa of all the 
seven histidine sidechains in folded TrAvrPto (Table 5.1).  Histidines H41, H103 and 
H130 display pKa values consistent with their solvent-exposed locations on the protein 
surface.  Histidines H75 and H125 have elevated and H54 has depressed pKa values. 
The remaining histidine H87 displays a dramatically low pKa value.  
15
N-
1
H fHSQC 
experiments were performed to obtain the folded (pF) and unfolded (pU) populations at 
various pH and 26.6 °C (Dawson et al., 2009).  The CD and Fl thermal denaturation 
experiments provided information on pH as well as temperature dependence of 
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TrAvrPto folding (Dawson et al., 2009).  The data (Figure 5.4 and 5.5) from three 
different biophysical methods agreed well to each other and conclusively proved the 
role of pH as a folding switch for TrAvrPto.  In order to elucidate the role of histidines 
as the tuners of this folding switch in the required pH-range, the model proposed by 
Yang and Honig (Yang and Honig, 1993) was employed. 
 
Figure 5.5:  Folded populations (pF) of WT TrAvrPto versus pH at 26.6 °C from NMR 
(♦), CD (○) and Fl (Δ) experiments. The solid line is the fitted curve to the Yang and 
Honig model considering the histidine sidechain and COOH titrations. This model 
nicely predicts the pF at all pH values. 
 
Yang and Honig (Yang and Honig, 1993) proposed a model for the pH-
dependence of protein stability (Figure 5.2).  The basis of this model is that the 
titratable groups in a protein should have different pKa values in the folded (F) and 
unfolded (U) states of the protein.  In the unfolded state, the titratable group in each 
type of amino acid should have the same pKa value.  Thus, all histidines should have a 
   
  of ~6.4, glutamates a    
  of ~ 4.8 and so on.  On the other hand, in the folded 
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state, each residue would have a different    
  value depending on whether it is 
surface exposed, buried, in a salt bridge or forming a hydrogen bond.  For example, 
H87, which is a buried residue in TrAvrPto, has a    
  of 4.8 in the folded state and 
   
  of 6.4 in the unfolded state.  Yang and Honig not only provided a sound physical 
model for the pH-dependent stability of proteins based on pKa values but also were 
able to provide rigorous mathematical equations relating the folding free energy 
(GF→U) to the    
  and    
  of the titratable residues in the protein, pH of the system 
and Gneutral, the denaturation free energy of the protein when all its titratable residues 
are in the neutral state.  The details of the model have been discussed in the Methods 
section. 
The pH-dependence of the folded population (pF) obtained from the CD, Fl and 
NMR experiments were fit to the Yang and Honig model (Figure 5.2). The titrations 
of all the seven histidines were considered simultaneously.  The    
  values obtained 
from the 
15
N-
1
H HMQC experiments (Table 5.1) and    
  = 6.4 (Nozaki and Tanford, 
1967) were used in the model.  The only fitting parameter, Gneutral, was obtained to be 
1.65 ± 0.03 kcal/mol.  This model was able to fit the high pH titration points from pH 
5 to 8 but was inadequate to predict the lower titration points (Figure 5.4).  This 
implies that the histidines which have their pKas in the range of 4.8 to 6.8 are not 
responsible for the titration of the protein in the lower pH range.  This is consistent 
with the Yang and Honig model (Yang and Honig, 1993).  While discussing the 
model, the authors have explained the unfolding transition of a protein in a pH-range 
as follows: “… the pKa of the responsible group does not correspond to the midpoint 
of the titration as is sometimes assumed.  Rather, there must be a group whose pKa is 
shifted from one value that corresponds to the beginning of the titration to another 
value that corresponds to its endpoint.  Thus, analyzing stability curves is 
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fundamentally different from analyzing standard titration curves since the endpoints 
rather than the midpoints serve as markers for the relevant pKas.” 
Since the pKas of the histidines in TrAvrPto range from 4.8 to 6.8, they tune 
the unfolding transition of the protein in that pH-range.  For the titration points from 
pH 2.0 to 4.8, the responsible residues should have their relevant pKas in the same 
range.  The sidechains pKas (Nozaki and Tanford, 1967) of aspartic acid (   
  = 3.9) 
and especially glutamic acid (   
  = 4.4) will be in the required range if their    
  is 
close to 2.0.  Hence, the model was modified to include two more fitting parameters 
        
  and         
  which are the pKas for the required sidechain COOH group in 
the folded and unfolded protein respectively.  For this model Gneutral = -0.74 ± 0.5 
kcal/mol,         
  = 2.7 ± 0.4 and         
  = 4.8 ± 0.05 was obtained and the model 
fits the experimental data well (Figure 5.5).  A favourable Gneutral indicates that the 
unfolded form is favored in the hypothetical neutral state (Figure 5.2) and hence, a 
contribution of favorable free energy would be required from the titratable residues in 
order to keep the protein folded in the neutral pH range. The contribution of each 
titratable residue to the stability of the protein is given by Gion (see methods and 
Figure 5.2). Calculating Gion for each residue as a function of pH (Figure 5.5) 
reveals that the COOH group and the His 87 are the major contributors to the protein‟s 
stability and destability, respectively.  Furthermore, the Gion contribution of the 
COOH group (2.9 kcal/mol at pH 6.5 and above) is too high for a single COOH 
involved in solvent-exposed salt bridge (Horovitz et al., 1990) and suggests that 
multiple COOH groups are involved in stabilization of the folded protein.  Thus, this 
modified model successfully explains the pH-dependent folding of TrAvrPto.  It also 
identifies the H87 residue as the key regulator of the pH-dependent folding switch and 
several sidechain COOH groups, involved in salt-bridges, providing the basic 
structural stability to the protein. 
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Figure 5.6:  Corresponding contribution (based on equation 6.2) of each His residue 
(H41(□), H54(♦), H75(◊), H87(○), H103(Δ), H125(▲), H130(●)) and COOH(■) 
group to the Gion of the protein as a function of pH.  This figure is adapted with 
permission from Dawson et. al., 2009. 
 
The contribution of the H87 residue to the pH-dependent folding switch was 
tested by H87Y-TrAvrPto mutant (Dawson et al., 2009). Fl data of the pH-titration of 
the H87Y mutant shows a significantly lower acid denaturation (Figure 5.7).  This data 
was modeled using the same pKa values of all histidine residues (excluding H87), 
        
  and         
  of the WT TrAvrPto. The Gneutral was allowed to vary and 
the model fits the H87Y fluorescence data well (Figure 5.7). The fitted Gneutral (-0.68 
± 0.01 kcal/mol) is less than that of the wildtype protein (-0.74 kcal/mol) and indicates 
that the H87Y mutation has shifted the F
neutral
 → Uneutral equilibrium toward Fneutral.  
These results remarkably support the two-state multi-titration model (Figure 5.2) and 
confirm the central role of H87 in tuning the pH-dependent stability of TrAvrPto in 
the pH range of 5 to 7. 
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Figure 5.7:  Folded populations (pF) versus pH at 26.6 °C for the WT from NMR (♦), 
CD (○) Fl (△) experiments and for H87Y from Fl (▲) experiment. The solid grey line 
is the fitted curve to the Yang and Honig model considering the histidine sidechain 
(except H87) and COOH titrations.  The solid black line is for the WT protein.  The 
H87Y mutant shows markedly increased pH-dependent stability as compared to the 
WT.  This figure is adapted with permission from Dawson et. al., 2009. 
 
Discussion 
The unfolding requirement of effector proteins in order to translocate through 
the T3SS is a widely debated topic in the literature.  As discussed in several reviews 
(Galan and Wolf-Watz, 2006; Ghosh, 2004) of the T3SS, the results from various 
biochemical and in vivo experiments, done to prove or disprove this unfolding 
requirement, are not conclusive.  Here, we have shown that a pH-regulated folding 
switch operates in AvrPto that would facilitate its unfolding in the bacterial cytoplasm 
and refolding in the host cytoplasm (Figure 5.1).  A single histidine residue, H87, acts 
as a pH sensor and tunes the acid denaturation of the protein in the biologically 
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significant pH range of 6.0 to 7.5.  The Yang and Honig model (Figure 5.2) elegantly 
explains  
 
Figure 5.8:  The N-terminus of the effector protein YopH (PDB ID 1HUF) showing 
the three surface exposed histidines. 
 
125 
 
these observations in terms of    
 and    
  of the titratable residues of the protein and 
highlights the role of buried histidine H87 as well as COOH salt-bridge in the 
protein‟s stability.  Thus, this work beautifully illustrates the role of titratable groups 
in tuning the pH-dependent stability of effector proteins and it will be interesting to 
see whether the proposed pH-folding switch can explain some of the ambiguities 
discussed in the literature. 
 
Figure 5.9:  The phosphatase domain of the effector protein YopH (PDB ID 1QZ0) 
showing the exposed histidine H350.  The histidines H270 and H402 are buried in the 
core pf the protein and also from hydrogen bonds with Y301 residue sidechain. 
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As mentioned earlier, fusion of the N-terminal secretion signal of YopE to the 
destabilized mutant of DHFR led to its secretion through the T3SS, while the stable 
WT DHFR was secretion incompetent.  In a detailed review of T3SS (Ghosh, 2004) 
the author pointed out that the stability of WT DHFR (~5 to 6 kcal/mol) is similar to 
that of YopH (~6 kcal/mol) and the RhoGAP domain of YopE (~7 kcal/mol) effector 
proteins.  This raises the question that with similar stability how do the effector 
proteins get secreted while the WT DHFR does not?  As another example, the highly 
stable Green Fluorescent Protein (GFP) is readily secreted when fused with the N-
terminus secretion signal.  GFP has a beta-barrel structure with a diameter of ~3.5 nm, 
which makes it virtually impossible for GFP to go through the T3SS without 
unfolding.  Keeping in mind the pH-folding switch, a detailed investigation on the pH-
dependence of the stability of these proteins might answer these questions. 
There are three histidines in each of the N-terminus (residues 3 to 125, PDB ID 
1HUF, 1K46, 1MOV) and the phosphatase domain (residues 167 to 468, PDB ID 
1Q70) of YopH.  The histidines H9, H62 and H83 in the N-terminus are surface 
exposed and hence, should not contribute much to the pH-dependent stability of YopH 
(Figure 5.8).  In the larger phosphatase domain only H350 is surface exposed.  
Histidines H270 and H402 are completely buried in the core of the domain and the 
N2 of each sidechain also form H-bonds with the sidechain of Y301 (Figure 5.9).  It 
can be predicted that these two histidines will have very depressed    
  and, based on 
the Yang and Honig model (Yang and Honig, 1993), should contribute to the pH-
dependent unfolding of YopH.  Also the stability of YopH (~6 kcal/mol) was 
measured at a pH = 8 (Birtalan et al., 2002), which being basic should favor the folded 
state. 
For YopE, two crystal structures have been reported, one for N-terminus 
(PDB: 1HY5) and other for the chaperone binding region of YopE in complex with its 
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chaperone SycE (PDB: 1L2W).  Not enough structural information is present in these 
fragments in order to make predictions regarding the effector‟s pH-dependent stability. 
Figure 5.10:  The core of Cya shows buried residues D188, D190 and H298. 
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Interestingly, GFP also displays pH-dependent stability (Alkaabi et al., 2005; 
Penna et al., 2004).  Alkaabi and co-workers have shown that GFP is highly stable at 
pH 7.5 and 8.5 but has drastically reduced stability at pH of 6.5.  The reduced stability 
of GFP at pH 6.5 (approximate internal pH of the pathogens) would facilitate its 
secretion through the T3SS when fused with the secretion signal.  Thus, the pH-
dependent folding switch can partially explain some of the ambiguous observations 
made in the literature regarding the translocation of effector proteins through the 
T3SS. 
The biochemical assay for the in vivo detection of the effector protein 
translocation is done by the use of Effector-Cya fusion protein, where the Cya is an 
adenylate cyclase that produces cyclic AMP (cAMP) once inside the host cell and the 
detection of cAMP produced reports on the level of translocation.  Cya is a calmodulin 
dependent enzyme (Botsford and Harman, 1992) and since prokaryotes lack 
calmodulin, the Cya fusion protein produces cAMP only after translocation to the host 
cell.  This strategy was first used to study translocation of YopE from Yersinia 
enterocolitica into HeLa cells (Sory and Cornelis, 1994).  A bacterial adenylate 
cyclase was used from Bordetella pertussis.  The same strategy was used to develop a 
biochemical assay for the detection of translocation of AvrBs2 effector protein into 
plant cells (Casper-Lindley et al., 2002).  The success of this assay depends on the 
efficient translocation of the Effector-Cya fusion protein.  The crystal structure of Cya 
from Bordetella pertussis has been reported (PDB ID 1YRT).  Cya has a minimum 
dimension of ~4.2nm and hence, has to unfold in order to pass through the T3SS.  It 
has eight histidines out of which H108 is partially buried and H298 is completely 
buried.  There are two aspartic acids D188 and D190 within 3.5Å of H298 and are also 
partially buried (Figure 5.10).  D198 sidechain also forms a hydrogen bond with 
H298.  Based on the Yang and Honig model (Yang and Honig, 1993) we can predict 
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that D188, D190 and H298 would impart pH-dependent stability to Cya and facilitate 
its facile translocation through the T3SS. 
Thus, the pH-dependence of protein stability has added a new dimension to our 
understanding of the T3SS.  Nature has elegantly utilized this pH-folding switch to 
unfold effector proteins inside the pathogens, deliver them through the T3SS and again 
refold them once inside the host cell.  The same folding switch has, serendipitously, 
served us in developing biochemical assays to study the T3SS.  It will be interesting to 
see how our detailed knowledge of the pH-folding switch helps us in understanding 
bacterial virulence and T3SS. 
  
130 
 
CHAPTER 6 
FUTURE DIRECTIONS AND PERSPECTIVES 
*
 
 
This work studied, at the molecular level, the role of the peptidyl-prolyl 
isomerase Pin1 and its substrates the cis/trans isomers of pAICD (AICD 
phosphorylated at T668) in Alzheimer‟s disease (AD).  One major outcome of this 
work is the proposed role of Pin1 as a connector and flux modulator of protein 
interaction network modules.  This proposed role provides for the first time a 
molecular basis to explain the impact of Pin1‟s enzymatic action on various cellular 
processes and hinges upon the assumption that the substrate and product of Pin1 
enzymatic action, i.e. cis and trans isomers, participate in isomer-specific interactions.  
Even though several examples of trans-specific interactions are known, identification 
of cis-specific interactions are yet to be made (here trans and cis refer to the 
phosphorylated substrates of Pin1).  This work also contributed towards the design and 
synthesis of peptide analogues of the cis and trans isomers which are currently being 
used in the Nicholson lab for the identification of the pAICD cis/trans isomer-specific 
binding partners in the cell.  Identification of these putative binding partners would 
open up exciting new frontiers of research.  First, such isomer-specific binding 
partners, for both the isomers, can be used in rationally designed interaction network 
modules to experimentally show the impact of Pin1 activity as a connector and flux 
modulator of these modules.  Second, identification of isomer-specific binding 
partners would provide important clues in understanding the signaling pathways that 
the cis and trans isomers of pAICD are involved in and should guide future 
experiments, both NMR and cell biology based.  Finally, such binding partners can be 
____________________________ 
* Parts of this chapter are based on a manuscript submitted to Nature Chemical Biology. 
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targeted for therapeutic purposes in Alzheimer‟s disease. 
 
Speculating the roles of cis and trans isomers of pAICD in AD 
As described in detail in the first chapter, the phosphorylation of T688 in the 
cytoplasmic tail of APP is regarded as an important signaling event that plays a major 
role in deciding the processing fate of APP.  The key question that arises is, how does 
the phosphorylated T668 influence APP processing?  Two mechanisms can be 
postulated to answer this.  First, T668 phosphorylation dictates the localization of APP 
in the cell and thus, influences its processing.  For this case, the pT668 would have to 
be in the full length APP.  The pT668-P669 trans-specific interaction network might 
be involved in APP trafficking to the plasma-membrane or out of the endosomes thus, 
favor the non-amyloidogenic processing whereas the corresponding cis-specific 
interaction network might be involved in endocytosis thus, favor the amyloidogenic 
processing.  We have demonstrated using mathematical modeling that the cis-specific 
interaction network becomes dominant as compared to the trans-specific interaction 
network only in the absence of Pin1.  Thus, it seems that this postulate can explain the 
observed increase in amyloidogenic processing of APP in the absence of Pin1.  But 
there is a severe drawback in this postulate.  Even though the cis-specific interaction 
network becomes dominant in the absence of Pin1, the flux through it is much smaller, 
owing to the small population of cis isomer, than the flux through the 
dephosphorylated APP interaction network which most probably favors the non-
amyloidogenic processing of APP.  This might be a key factor in the slow onset of the 
Alzheimer‟s disease.  The hypothesized role of cis-isomer, that it enhances 
amyloidogenic processing of APP in the absence of Pin1, can also be explained if the 
longer lived signal (i.e. cis-isomer) gets amplified.  This leads us to the second 
mechanism that the cis-isomer in the C-terminal fragment of APP, i.e. pAICD formed 
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after the γ-secretase activity, enhances the transcription of certain factors that take part 
in trafficking and processing of APP. 
Under diseased condition, T668 phosphorylation increases (Lee et al., 2003b) 
and Pin1 is down regulated (Huang et al., 2010).  Also it has been observed that APP 
processing increases in Pin1-knockdown cells (Pastorino et al., 2006).  These 
observations can be explained if the cis or trans isomer of pAICD fragment promotes 
the transcription of α, β and γ-secretases.  Taking account of all the possibilities 
presented above, we can postulate a hypothetical model for the signaling pathways 
involving cis and trans isomers of pAICD. 
1. The trans isomer in full length APP is most probably involved in APP 
trafficking towards the plasma membrane and/or out of the endosomes.  
Thus, it favors the non-amyloidogenic processing of APP. 
2. In the absence of Pin1, the insulated trans-specific interaction network 
module of pAICD fragment is involved in the transcription of α, β and 
γ-secretases.  In the presence of Pin1, the cis and trans specific network 
modules are connected and the flux through the trans module is less, 
resulting in the lower levels of transcription of α, β and γ-secretases. 
3. In the absence of Pin1, the insulated cis-specific interaction network 
module of pAICD fragment is involved in the transcription of cellular 
factors that recognize the endocytic signal in the cytoplasmic tail of 
APP and promote its endocytocis.  Even though the flux through the 
cis-specific network module is lower in the absence of Pin1, its 
prolonged activation would eventually lead to greater transcription of 
the cellular factors involved in the endocytocis of APP.  Thus, the cis 
isomer of pAICD, in the absence of Pin1, can enhance the 
amyloidogenic processing of APP. 
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4. There is no clear evidence in the literature that correlates down 
regulation of Pin1 and phosphorylation levels of T668 in APP and in 
tau proteins.  It would be interesting to compare the phosphorylation 
levels of these proteins in wild type and Pin1 knockout (or knockdown) 
cells.  Also, it would be interesting to compare the expression levels of 
the proline-directed kinases and phosphatases in these two cell types. 
 
Lineshape analysis of PPIase domain and full length Pin1 
The current work demonstrated the power, sensitivity and reliability of NMR 
lineshape analysis in determining the kinetics of protein-ligand interaction by studying 
the interaction of the isolated Pin1-WW domain and pAICD derived peptide 
pAPP659-682.  The next step will be to study the interaction of isolated Pin1-PPIase 
domain and pAPP659-682.  The interaction models for isolated Pin1-WW domain and 
isolated Pin1-PPIase domain are shown in Figure 6.1a and 6.1b, respectively.  The 
trans isomer specificity of the WW domain simplified the lineshape analysis of this 
interaction.  For the peptide perspective of this interaction, only the peaks 
corresponding to the trans isomer were analyzed while the slow isomerization of the 
free cis to free trans isomer was accounted for in the thermodynamic equations of the 
fitting model.  Similar simplification is not possible for the PPIase domain, since it 
interacts with both the isomers and catalyzes their isomerization.  Analysis of the 
protein perspective is relatively simpler.  For each residue of the protein, there is only 
one peak that corresponds to the free state (Figure 6.1b, state P) and only one peak that 
corresponds to the bound state which is the population weighted average of the bound 
cis (Figure 6.1b, state E) and bound trans states (Figure 6.1b, state D) due to exchange 
in the fast timescale between them.  Complications arise in the analysis of the peptide 
perspective of this interaction.  For each residue of the peptide, there are two peaks for  
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Figure 6.1:  Fitting models for NMR lineshape analysis.  The peptide and protein 
perspective models for a) isolated WW domain, b) isolated PPIase domain, and c) full 
length Pin1.  Only the states observable by NMR are accounted for in the models.  The 
single letter symbols used to identify each state are consistent for all the models.  The 
microscopic rates for each step are also consistent for all the models. 
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the free state corresponding to free cis (Figure 6.1b, state A) and free trans (Figure 
6.1b, state B), respectively.  This poses some practical problems in terms of the 
implementation of lineshape analysis in BiophysicsLab.  Since the cis and the trans 
isomers appear as two distinct peaks, their lineshapes are extracted as separate datasets 
(see Appendix 1) whereas for the actual fitting they need to be combined into a single 
dataset.  This would require additional processing of the extracted datasets from the 
labeled peptide titration to be able to fit to the model (Figure 6.1b, peptide 
perspective) using lineshape analysis.  This procedure would also be necessary for the 
fitting of the titration data of the full length Pin1 to the corresponding model (Figure 
6.1c, peptide perspective). 
For the lineshape analysis of the PPIase domain interaction with the peptide 
pAPP659-682, additional restraints for the microscopic rates (Figure 6.1b) can be 
obtained from catalytic rate constants measured from the 
1
H-
1
H ROESY experiments.  
The catalytic rate constants, kct and ktc, represent the cis to trans and trans to cis 
conversions, respectively.  These rate constants are related to the Michaelis-Menten 
constant (KM) and rate constant (kcat) as follows 
    
   
   
  
               (6.1a) 
    
   
   
  
                (6.1b) 
In the above equations [E] is the free enzyme concentration.  The Michaelis-Menten 
constant (KM) and rate constant (kcat) are related to the microscopic rate constants 
(Figure 6.1b) as follows 
   
      
                    
                
      (6.2a) 
   
    
                    
                
      (6.2b) 
    
    
      
           
        (6.2c) 
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        (6.2d) 
Substituting equations (6.2) into equations (6.1) we get 
    
         
                    
         (6.3a) 
    
         
                    
         (6.3b) 
The free enzyme concentration [E] in the ROESY experiment will be approximately 
equal to the concentration of the total enzyme used in the experiment.  Otherwise, it 
can also be calculated from the dissociation constants KD
cis
 and KD
trans
, which should 
be fitting parameters in the lineshape analysis.  Similar approach can be used for the 
lineshape analysis of the full length Pin1 titration data. 
In conclusion, the studies completed thus far lay important groundworl for 
elucidating the microscopic rate and equilibrium constants for the Pin1 reaction 
scheme.  Important insights have emerged from this work, including a novel proposed 
role of Pin1 as a connector and flux modulator of protein interaction network modules, 
and an appreciation of the power and sensitivity of NMR lineshape analysis.  The 
kinetic and thermodynamic characterization of Pin1 will provide a foundation on 
which to elucidate detailed mechanisms involved in the binding and catalytic functions 
of this enzyme through similar studies using Pin1 mutants. 
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APPENDIX 1 
PRACTICAL ASPECTS OF LINESHAPE ANALYSIS 
The first step is to perform the titration experiment and collect 
15
N-
1
H HSQC 
spectrum for each titration point.  The following points should be considered while 
designing and performing the experiments: 
1. If there is enough protein then always use the dilution method for 
titration.  Start with the most saturated sample and keep on diluting it 
with the 
15
N-labeled component, so that the concentration of the labeled 
species is constant for all titration points.  The unlabeled component 
keeps getting diluted. 
2. Run the extreme points first i.e. saturated and the apo spectra.  This 
allows the determination of the minimum sweep widths  for both 
dimension. 
3. Adjust the sweep widths (sw, sw1 and dof2) to the minimum required. 
Use atleast np=2048 and ni=256.  It is always good to have more points 
define a peak. 
4. While processing data, use EM window function to maintain the 
lorentzian lineshape. 
5. Set zerofilling to auto, more points would hamper global fitting. 
Zerofilling can be increased later to produce better figures for 
publication. 
Once the data is collected, process it with nmrPipe and read it in sparky.  We 
are using BiophysicsLab (http://biophysicslab.net/) to perform the lineshape analysis.  
The raw data for lineshape analysis is generated using sparky.  Open all the spectra of 
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a titration experiment in sparky. Type „e5‟ or alternatively click „BiophysicsLab 1D 
NMR‟ as shown below. 
Clicking the above options a new dialogue box as shown below.  Once this 
dialogue box opens, click on „Assign indices‟.  This should open another dialogue box 
„Displaying the peak heights vs. interleave index‟.  In this dialogue box click the 
„Setup…‟ button.  A new dialogue opens which lists all the spectra opened in sparky.  
Check the button for all of them and number them from 1 to „n‟, where „n‟ is the 
number of titration points or spectra.  The apo spectra should be 1 and the most 
saturated one „n‟.  Click „OK‟ to close.  Close the previous one too.  Now select a peak 
to be analyzed.  Then click „Set current peak‟.  Drag a box around the peak and make 
sure to cover enough region, so that the peak in all the spectra come within the box.  
Under „Integrate SAME region in all spectra at once:‟ click „Remove w1‟.  This would 
get slices for the w2 (
1
H) dimension from all the spectra.  It would also indicate the 
number of slices integrated for each spectra (see figure below).  This method should 
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only be used for well isolated peaks.  Clicking on „Remove w2‟ does the same for w1 
(
15
N) dimension.  The above step is the first step for getting slices and should be used 
only once if slices from each spectrum are individually collected.  The other option 
(see figure below) can be used to get slices from each spectrum.  In this case, integrate 
one to three traces for each spectrum.  The raw data is saved in a folder named 
„Data_for_biophysicsLab‟ 
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Lineshape analysis using BiophysicsLab 
BiophysicsLab is implemented in matlab.  All the basic programs that 
constitute BiophysicsLab are in a folder named „code‟  It is necessary to add this 
folder in the path of matlab.  BiophysicsLab has two classes: 
1) Dataset: It is a superclass for all types of data. 
2) TotalFit: It contains methods that can load dataset objects and fit them to the 
user defined models. 
NMRLineShapes1D is a derivative class of Dataset and contains all the predefined 
as well as user defined models. This is the only class that we need to modify when we 
come up with a new model.  The important packages are: 
equilibrium_thermodynamic_equations, kinetic_matrices and 
line_shape_equations_1D.  The class folders start with the „@‟ sign and the package 
folders start with the „+‟ sign and are located in „code‟ folder.  The working folder 
should have two folders: 
1) Data_for_BiophysicsLab: This is created by sparky and has your NMR data. 
2) BiophysicsLab: This is the data is fit. Create three subfolders for 
BiophysicsLab. 
I. 1_Preprocess 
II. 2_Individual_fits 
III. 3_Global_fit 
Now setup the fitting model.  Use MuPad to derive the thermodynamic 
equilibrium populations for all the species i.e. free ligand, free protein and bound 
protein.  In „code‟ go to the folder „+equilibrium_thermodynamic_equations‟ and 
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create a file named „U_L_model.m‟ and define all the equilibrium values.  Determine 
the rate-matrix and write it in the file „U_L_model_K_matrix.m‟ in the folder 
„+kinetic_matrices‟.  Create the file „U_L_model_1D.m‟ in the folder 
„+line_shape_equations_1D‟ to generate 1D lineshapes.  Finally add the model to the 
file „NMRLineShapes1D.m‟ in the folder „@NMRLineShapes1D‟. 
Before the actual lineshape fitting, it is necessary to preprocess the data.  This 
is done in the folder „1_Preprocess‟.  An example processing file is „A31_w2.m‟.  
Here load the data and visualize the slices, trim to remove overlap or extra baseline 
and finally normalize the slices to unit area.  Any simple model can be used for the 
initial guess and the whole session is saved.  Saving the sessions lets us to start from 
the point where we stop.  The actual lineshape fitting for an individual dataset is done 
in the folder „2_Individual_fits‟.  An example of a processing file is 
„A31_w2_U_L_1.m‟.  The following are the important points to be kept in mind while 
setting up this file: 
1. session.batch_link_parameters_in_series(series_name, [1   3 4 5 6 7 8 9 
10 11]).  Here list all the parameters in the model expect the second one 
which is the ligand-to-protein ratio and changes for each titration point. 
2. ideal_parameters=[ Rtotal 1e-4 6e4 0.08974359 2000 w0_1 w0_2 
FWHH_1 FWHH_2 1 0.4 ].  The ideal parameters should be guessed 
well to get realistic solutions.  If the fitting gives negetive value for 
some parameter, then change the initial value for that parameter and try 
again.  Sometimes changing some other parameter also helps. 
3. session.set_parameters_modes(1,[0 0 1 0 1 0 1 0 0 0 1]).  This array has 
the same number of elements as that of the number of parameters in the 
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fitted model.  The entry corresponding to the parameter that is being fit 
is „1‟ while the parameter that is not being fit is „0‟. 
4. main_session.fit_only('Newton').  This is the fitting routine.  Here the 
confidence limits of the fitted parameters are not determined. 
5. In order to determine the confidence limits of the fitted parameters, set 
the range for the parameters.  An example is the file 
„A31_w2_U_L_1_MC.m‟. 
6. min_values= [0 0  0   0 0   0   0   0   0   0  0].  max_values= [1 20 1e6 1 
1e6 1e6 1e6 1e3 1e3 10 1];  This sets the range for all the parameters. 
7. session.fit('simplex', 'single-core').  This is the fitting routine. 
8. Remember that the positions of peaks govern the binding constant and 
their lineshapes govern the binding rates. 
An example file for global fitting is „global_U_L_1.m‟.  The important 
features are as follows: 
1. In global fitting it is important to define the global parameters (such as 
kOFF and KD) and make sure it is the same (i.e. linked) for all datasets. 
2. main_session.link_parameters();  This routine links all the global 
parameters. 
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APPENDIX 2 
DECIPHERING THE INFORMATION ON PIN1 CATALYSIS OBTAINED 
FROM NMR 
1
H-
1
H ROESY EXPERIMENT 
The 
1
H-
1
H ROESY experiment is performed to obtain the rates of 
isomerization kct and ktc between cis and trans isomers of pAICD derived peptides as 
shown in equation (1).  The intrinsic conversion rates are too slow to be detected by 
ROESY experiments.  Addition of catalytic amount of Pin1 accelerates this rate and 
then the catalytically enhanced rate constants kct and ktc can be measured by ROESY 
experiments.  In order to understand the physical meaning of these catalytically 
enhanced rate constants measured by ROESY, we have to consider the actual physical 
process taking place inside the NMR tube. In order to measure the rate constants, 
several ROESY experiments are performed with different mixing time (tmix) which 
range from 5ms to 200ms.  The NMR experiment is done under equilibrium 
conditions and it does not perturb the system to change the equilibrium populations.  
Hence, at any given time we have 7% cis and 93% trans populations of the two 
isomers.  The two isomers have distinct chemical shifts.  The molecules which do not 
isomerize during the mixing time contribute to the diagonal peaks, i.e. if a particular 
peptide is in cis conformation at the beginning and at the end of the mixing time of a 
ROESY experiment, then that molecule would contribute to the cis diagonal peak of 
the spectrum.  On the other hand, those molecules that isomerize during the mixing 
time give rise to the cross-peaks. 
As an illustration, let assume that there are 1000 peptide molecules, so that 70 
are cis and 930 are trans.  If we consider the cis molecules only then at the start of 
each acquisition we have 70 molecules as cis.  After we wait for time tmix some of 
those cis get converted to trans.  As we increase tmix we get more and more of the cis 
converted to trans (giving the signal Ict) and also some of those trans being converted 
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back to cis (adding to the cis not yet converted to trans and giving the signal Icc). If we 
increase tmix to long enough time, then we will get equilibrium population i.e. 5 cis 
molecules (Icc) and 65 trans molecules (Ict).  Now, we have to figure out the true 
meaning of kct and ktc that we are measuring with ROESY experiment.   
 
                (1) 
 
For the reaction where cis is converting to trans, the initial reaction velocity 
(vin) is defined as: 
    
     
    
  
        
           
      
       (2) 
This is the well-known Michaelis-Menten equation.  For any substrate concentration, 
this equation can be rewritten as (Fersht p-111): 
   
    
    
  
                (3) 
Thus, kcat/kM is a second-order rate constant and [E]kcat/kM is a pseudo-first order rate 
constant.  This is a reasonable approximation since, under steady state condition the 
concentration of the enzyme-substrate complex is constant i.e. [ES] = constant.  
Therefore, the concentration of the free enzyme is also constant, [E] = [E0] – [ES] = 
constant.  Comparing equations (2) and (3) we get 
        
    
  
            (4) 
Now, we can derive an expression which we will use to fit the ROESY data and 
extract out kCT and kTC. For the cis to trans conversion, we have the following set of 
equations: 
Cis Trans 
kCT 
kTC 
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                      (5) 
 
    
  
                      (6) 
The boundary conditions for the above equations are: 
[C] = 1 and [T] = 0 at time t = 0.         (7) 
Solving the set of equations (5) and (6) and applying the boundary conditions (7), we 
get 
     
    
               
       
         (8) 
     
                      
       
        (9) 
Now ICC α [C] and ICT α [T], so ICT/ ICC = [T]/[C]. Therefore,  
 
   
   
 
                   
    
              
       (10) 
Similarly we get 
 
   
   
 
                   
    
              
       (11) 
Equations (10) and (11) are the expressions used to extract the exchange rate constants 
from ROESY data. 
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The plots for the above two expressions are shown below: 
Therefore, in conclusion we have shown that the catalytic conversion of cis to trans 
and vice versa is a pseudo-first order reaction and valid for all enzyme concentrations. 
The rate constants obtained from the ROESY experiments are related to kcat and kM as 
follows: 
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